The syndrome of angina pectoris with normal coronary angiogram by Albertsson, Per  1956-
©
Det här verket är upphovrättskyddat enligt Lagen (1960:729) om upphovsrätt till litterära och 
konstnärliga verk. Det har digitaliserats med stöd av Kap. 1, 16 § första stycket p 1, för forsk-
ningsändamål, och får inte spridas vidare till allmänheten utan upphovsrättsinehavarens 
medgivande. 
Alla tryckta texter är OCR-tolkade till maskinläsbar text. Det betyder att du kan söka och kopie-
ra texten från dokumentet. Vissa äldre dokument med dåligt tryck kan vara svåra att OCR-tolka 
korrekt vilket medför att den OCR-tolkade texten kan innehålla fel och därför bör man visuellt 
jämföra med verkets bilder för att avgöra vad som är riktigt.
This work is protected by Swedish Copyright Law (Lagen (1960:729) om upphovsrätt till litterära 
och konstnärliga verk). It has been digitized with support of Kap. 1, 16 § första stycket p 1, for 
scientific purpose, and may no be dissiminated to the public without consent of the copyright 
holder.  
All printed texts have been OCR-processed and converted to machine readable text. This means 
that you can search and copy text from the document. Some early printed books are hard to 
OCR-process correctly and the text may contain errors, so one should always visually compare it 
with the images to determine what is correct.
0
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20                                                
21
22
23
24
25
26
27
28
29
30
C
M
0
1
2
3
4
5
6
7
8
9
10
11
12
IN
C
H
THE SYNDROME OF ANGINA PECTORIS WITH 
NORMAL CORONARY ANGIOGRAM 
Per Albertsson 
Göteborg 1996 

University of Göteborg 
Division of Cardiology, Sahlgrenska University Hospital 
Göteborg, Sweden 
THE SYNDROME OF ANGINA PECTORIS WITH NO RMAL 
CORONARY ANGIOGRAM 
AKADEMISK AVHANDLING 
SOM FÖR AVLÄGGANDE AV MEDICINE DOKTORSEXAMEN VID GÖTEBORGS UNIVERSITET, 
OFFENTLIGEN FÖRSVARAS VID SAHLGRENSKA SJUKHUSET, 
SAL F3, TORSDAGEN DEN 23 MAJ, 1996, KL.13.00 
AV 
Per Albertsson 
leg. läkare 
Avhandling baseras på följande delarbeten: 
I Morbidity and use of medical resources in patients with chest pain and normal or 
near normal coronary arteries: Influences of the diagnostic angiogram. 
P Albertsson, H Emanuelsson, T Karlsson, C Lamm, W Sandén, G Lagerberg, / H erltiz. 
Submitted 
II Quality of life in patients with chest pain and normal or near normal coronary 
angiograms. 
P Albertsson, I Wiklund, H Emanuelsson, M Haglid, T Karlsson, H Sjöland, J Herlitz. 
Submitted 
III Coronary vasodilator capacity during atrial pacing and after adenosine administration in patients 
with syndrome X. 
P Albertsson, H Emanuelsson, C Lamm, F Waagstein. 
Submitted 
IV Adenosine infusion - Provocation of left ventricular dysfunction in patients with syndrome X. 
P Albertsson, V Kujacic, D jablonskiene, H Emanuelsson. 
Cor Europaeum 1994; 3:34-38. 
V Forearm endothelial function and plasma nitrate are unaffected in patients with syndrome X and 
respond normally to transdermal estrogen. 
B Wall, P Albertsson, I Milsom, H Emanuelsson, Å Wennmalm. 
Submitted 
VI Beneficial effect of treatment with transdermal estradiol-17-ß on exercise induced angina and ST-
segment depression in syndrome X. 
P Albertsson, H Emanuelsson, I Milsom 
Int J Cardiol. In press 
VII Spinal cord stimulation in angina pectoris with normal coronary arteriograms. 
T Eliasson, P Albertsson, P Hårdhammar, H Emanuelsson, L-E Augustinsson, C Mannheimer. 
Coronary Artery Disease 1993;4:819-827 
ABSTRACT 
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they were younger and more likely to be female (50 vs. 20%). The use of medical resources 
was reduced from a 66% percent need for hospitalisation two years prior to the angiography, 
compared to 35% during two years after the diagnostic procedure. Regarding self-estimated 
quality of life, this was considered significantly lower in patients with normal or near 
normal coronary arteries compared to patients with significant stenoses. This included score 
on Nottingham Health Profile I, Nottingham Health Profile II and Psychological General 
Well-Being Index. 
Patients with angina pectoris, positive exercise test and normal coronary angiogram 
(syndrome X) were provoked with adenosine, rapid atrial pacing and intravenous 
ergonovine. Spasm was not induced in any patient. The flow increase after intracoronary 
adenosine was similar compared to a control group, but patients with syndrome X showed a 
lower flow increase after rapid atrial pacing. Four of 13 patients in the study group showed 
signs of lactate production during rapid atrial pacing compared to none in the control group. 
After intravenous adenosine provocation, 14 of 20 patients with syndrome X were found to 
show signs of significant aggravation of left ventricle dysfunction as opposed to only 4 of 17 
patients with atypical chest pain and none of 10 healthy subjects. 
Intra-arterial administration of acetylcholine resulted in a dose-dependent increase in 
forearm blood flow that was similar in patients with syndrome X and in controls. The same 
was found for the endothelium independent vasodilator sodium nitroprusside. 
Fifteen postmenopausal women with syndrome X were performing exercise tests during 
placebo treatment and during transdermal estrogen treatment. Time to angina increased 
significantly and so did total exercise time. The ST-segment depression on comparable 
workload was significantly reduced during active treatment. 
Spinal cord stimulation during exercise test was investigated in 11 patients with syndrome 
X. Compared to the control situation, the rate pressure product and the maximal workload 
significantly increased and ST-segment depression in comparable workload was reduced 
from 1.5 to 1.0 mm . 
In conclusion, patients with angina pectoris and normal coronary angiogram have an 
inferior quality of life compared to patients with coronary artery stenoses, but need for 
hospitalisation was reduced after the diagnostic angiogram. Patient with syndrome X have 
a reduced coronary flow reserve on rapid atrial pacing whereas flow reserve in the forearm 
was normal. Left ventricular dysfunction could be induced with adenosine. A beneficial 
treatment effect was shown with both estrogen treatment and spinal cord stimulation. 
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INTRODUCTION 
Background 
Soon after the advent in the early 60's of 
coronary angiography, it became clear 
that among those patients reporting 
chest pain, some have normal coronary 
angiograms. The first report was 
published in 1967 (Likoff et al 1967) 
where 15 women with chest pain, ECG 
abnormalities, and normal coronary 
angiogram were described. 
Soon thereafter a study was reported 
by Kemp regarding 50 patients with 
chest pain and normal coronary angio­
grams (Kemp et al 1967). In this series 
62% of the patients were female and 
angina was considered typical in only 
30%. These pioneer works addressed 
several important features that are still 
applicable today; the female predomin­
ance, severe chest pain which can often 
be atypical, and lack of efficacy with 
conventional pharmacological treat­
ment. The term syndrome X was first 
used by Kemp in an Editorial comment 
accompanying an article by Arbogast 
and Bourassa in the American Journal of 
Cardiology in 1973, comparing a group 
of patients with angina and normal 
coronary arteries (group X) with a group 
of patients with angina and coronary 
artery stenosis. In this study, left ventri­
cular function was normal during rapid 
atrial pacing in group X in spite of 
"ischemic" ST-segment depression. 
Kemp used the term "syndrome X" to 
denote the heterogenicity of t he patients 
and the uncertainty of the ethiology 
behind the symptoms. More than twenty 
years later the term syndrome X is 
unfortunately still appropriate. 
Definition 
There are no consensus how to properly 
define this syndrome, which leads to 
great difficulties regarding comparisons 
between different trials where different 
populations have been studied. 
Except for angina pectoris and a 
normal coronary angiogram, signs of 
myocardial ischemia is most often 
required for the diagnosis of syndrome 
X. 
Furthermore the absence of inducible 
spasm is often, but not always, desirable 
as is exclusion of patients with systemic 
hypertension, valvular heart disease, left 
ventricular hypertrophy and cardio­
myopathy. 
In this thesis the following criteria are 
used to define syndrome X; 
1. Exercise induced angina pectoris. 
2. Normal coronary angiogram. 
3. Normal left ventricular function at rest. 
4. No signs of spasm angina. 
5.Positive exercise test with >lmm 
horizontal or doum-sloping ST-segment 
depression, 60 ms from the ]-point. 
There are clear drawbacks with the use 
of exercise test as a marker for myo­
cardial ischemia (discussed in more 
detail on p.46), but simply, it has a long 
tradition and is the most widely used 
provocation method. 
Incidence 
The true incidence of syndrome X i n a 
population with angina pectoris is not 
known. Since a normal coronary angio­
gram is mandatory for the diagnosis, it 
is plausible that only patients with 
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severe symptoms are properly diag­
nosed. In a sub-sample of middle-aged 
men, derived from the Primary 
Prevention Trial in Göteborg, however, 
the incidence of normal angiogram in 
cohorts with angina pectoris can be 
calculated (Hagman et al 1987). Two age-
cohorts (47 and 48 years) of men living 
in Göteborg were investigated. Of 1432 
subjects 70 (4.9%) were considered to 
have angina pectoris. Of these, coronary 
angiography was performed in 25 sub­
jects of whom 15 had no significant 
stenoses (1 minor irregularity and 14 
completely normal angiogram). This 
gives a maximal incidence of normal 
angiogram of 60% (15/25) and a mini­
mal incidence of 21% (15/70). 
In observational studies among 
patients performing coronary angio­
gram, 7-30% are reported to have 
normal coronary arteries (Proudfitt et al 
1966, Likoff et al 1967, Pasternack et al 
1980, Kemp et al 1986, Phibbs et al 1988), 
and reportedly 50% of these show 
positive exercise tests (Kemp et al 1973). 
There are, however, authors who believe 
the true incidence of syndrome X is 
substantially lower, and an ischemic 
origin of chest pain could be as low as 
1% among patients with normal 
angiograms (Hutchinson et al 1988). 
"Proof" for ischemia  
The presence of chest pain and ST-
segment changes are suggestive, but not 
conclusive evidence for an ischemic 
origin in syndrome X. 
Since lactate is the end product of 
anaerobic glycolysis, its release to the 
coronary sinus has been regarded as one 
of the most important indications for 
ischemia. It is then natural that a 
demonstration of lactate production is 
considered to be one of the best 
evidence for presence of ischemia in 
syndrome X. 
In different trials the proportion of 
lactate production varies between 10 
and 40% among patients with syndrome 
X (C annon et al 1987,1992, Opherk et al 
1981, Greenberg et al 1987, Berland et al 
1984, Virtanen 1984). In Cannons work 
where a reduced coronary flow was 
demonstrated on atrial pacing after 
ergonovine, lactate consumption was 
considerably lower in patients with a 
vasoconstrictor response and lactate 
production was seen in only 10% 
(Cannon et al 1987), and in Opherks 
work back in 1981, 5 of 21 patients can 
be identified as producing lactate during 
rapid atrial pacing. Already in one of the 
pioneer works, lactate metabolism 
investigation was undertaken and 9 of 
29 patients were found to be lactate-
producers. Simultaneous pacing did not 
induce left ventricular abnormality in 
this group of patients (Boudoulas et al 
1974), which is rather conflicting since 
deterioration of left ventricular function 
represents another parameter indicative 
of myocardial ischemia. Numerous 
works have followed, some of which 
have shown a deterioration of left 
ventricular function during induction of 
ischemia (Berger et al 1981, Wieshammer 
et al 1986). 
Cannon and co-workers demons­
trated that during rapid atrial pacing 
after ergonovine administration, 26 of 33 
patients showed a reduced coronary 
vasodilator capacity, and this group had 
a higher left ventricular end-diastolic 
pressure and reduced left ventricular 
ejection fraction during exercise, 
compared to the seven individuals with 
normal vasodilator capacity and a group 
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of 52 control patients (Cannon et al 
1985). 
In conclusion, both lactate production 
and left ventricular dysfunction have 
undoubtedly been demonstrated, at 
least in subgroups of patients with 
syndrome X. The discrepancy in these 
results could partly be explained by the 
variance of populations that have been 
investigated: For example, one study 
indicate that only female patients with 
syndrome X, and not men, have a fall in 
ejection fraction during exercise (Favaro 
et al 1987). In some investigations both 
patients with hypertension and diabetes 
mellitus have been included (Greenberg 
et al 1987), which also tends to confuse 
the issue. 
...and doubts 
The conflicting data that has been found 
regarding syndrome X has led to doubts 
about the aetiology of chest pain, and 
the hypothesis that syndrome X is a non­
ischemic syndrome, is well in concord­
ance with the excellent prognosis. 
The described findings with myo­
cardial lactate production and left 
ventricular dysfunction are, of course, 
challenged by investigators with contra­
dictory results. Even in the first experi­
mental work in this field (Arbogast and 
Bourassa 1973), the findings were 
obscure with ST-segment depression 
without left ventricular dysfunction 
after rapid atrial pacing, similar results 
have been reported by others (Gibbons 
et al 1981). 
One of the most cited works that has 
been performed recently covered post-
exercise echocardiography in 18 patients 
with syndrome X, which failed to 
demonstrate any disturbance in left 
ventricular function in spite of signifi­
cant ECG-changes (Nihoyannopoulos et 
al 1991). 
There are even findings suggesting 
that patients with syndrome X ha ve left 
ventricular hypercontractility during 
exercise (Picano et al 1987, Tousoulis et al 
1993). 
Myocardial metabolism has recently 
been investigated in 12 women with 
"typical angina pectoris" and positive 
exercise test (Camici et al 1991), and the 
authors were not able to document any 
metabolic alterations indicative of 
ischemia and concluded; "in patients 
with syndrome X the symptoms, 
electrocardiographic signs and impair­
ment in the increase in great cardiac 
vein flow during pacing co-exist with 
preserved global and regional left 
ventricular function and myocardial 
energy efficiency". 
Support that only a small fraction of 
patients with syndrome X have myo­
cardial ischemia was found in a study by 
Crake and co-workers (Crake et al 1988). 
When coronary sinus oxygen saturation 
was measured continuously during 
incremental pacing, patients with 
coronary artery disease (CAD) 
responded with a fall in saturation 
which was not normalised until pacing 
was discontinued. Ten patients with 
syndrome X responded in a very 
heterogeneous way. Six of ten had ST-
segment depression but only two had a 
fall in coronary sinus saturation in a 
manner similar to CAD patients. In five 
patients the saturation was unchanged 
(as in healthy controls) and in three the 
saturation gradually increased through­
out the procedure, in spite of the 
presence of ST-segment depression. The 
authors interpret these findings as such 
that only a small proportion of patients 
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with syndrome X really have an 
ischemic heart condition. 
A very interesting hypothesis has 
been introduced by Philip Poole-Wilson: 
Potassium is released from the myo­
cardium when the heart rate is in­
creased, and on cessation of the tachy­
cardia the small net loss of potassium is 
replaced. If patients with syndrome X 
have a deterioration in release (to much) 
or uptake (to slow) of potassium, it 
would be retained in the myocardium. 
The retention of potassium would 
explain both the chest pain and the ST-
segment depression (Poole-Wilson 1984, 
1989, Webb et al 1986,1987). 
This hypothesis has, in a way, been 
supported by Waldenström and co­
workers discovery of metabolic derange­
ment in muscle biopsies from patients 
with chest pain and abnormal 201-
thallium scan. They demonstrated a low 
energy charge with an inverse or an 
equalised ATP/ADP ratio. Low ATP 
could be explained by an ischemic 
condition, but on biopsy specimens 
taken during resting conditions and 
during ischemia, ATP levels were higher 
than ADP levels. A suggestion is that an 
excessive ion pumping is present in 
order to restore the transmembrane 
gradients of K+ ions. The elevated 
lactate levels that were found could 
reflect enhanced K+ pumping due to 
increased leakage (Waldenström et al 
1992). 
The discussion whether syndrome X 
is an ischemic or non-ischemic condition 
will probably continue. A reasonable 
prediction is that "both sides" will 
eventually be proven correct. We have 
to realise that syndrome X is not one 
disease, but a syndrome consisting of 
different populations with several 
different mechanisms behind the 
symptoms. 
Coronary circulation 
Since the heart never rests it needs large 
quantities of energy, mostly in form of 
oxidative metabolism which generates 
ATP (adenosine triphosphate). The myo­
cardium is almost totally dependent on 
aerobic metabolism. Oxygen-independ­
ent glycolysis, during anoxia, contri­
butes to no more than approximately 7% 
of ATP formation (Neely et al 1974). 
Therefore, in steady state, determination 
of the rate of myocardial oxygen con­
sumption (MVQ2) constitutes an 
accurate measurement of the total meta­
bolism. 
The principal determinants of M VO2 
are heart rate, contractility, and wall 
stress [volume x chamber pressure 
divided by wall thickness] (Graham et al 
1968). Additional important factors are 
the direct metabolic effect of 
cathecolamines and properties to utilize 
fatty acids. 
Myocardial ischemia occurs when 
MVO2 exceeds the coronary arteries 
capacity to deliver oxygen. Induced 
myocardial ischemia leads to anaerobic 
glycolysis in the tissue, resulting in a 
release of la ctate, contrary to the normal 
perfused heart which extracts lactate. 
The strong correlation between myo­
cardial blood flow, ischemia and 
regional myocardial function has been 
demonstrated especially regarding sub­
endocardial blood flow (Downey 1976). 
Coronary flow is phasic with the 
preponderance of flow occurring during 
diastole (Chilian et al 1982), and the flow 
is determined by the driving pressure 
(aortic pressure) and the coronary 
resistance. 
12 Per Albertsson 
The coronary resistance is an additive 
quantity of vascular and extravascular 
forces. An increased resistance during 
systole (due to twisting and shearing of 
the vessels during heart contractions), 
represents a small part of the total 
resistance. The predominant element in 
extravascular resistance is the intra­
ventricular diastolic pressure which is 
transmitted mostly to the subendo-
cardium to a greater extent than to the 
subepicardium. This can lead to limited 
subendocardial flow in the presence of 
an elevated left ventricular end diastolic 
pressure. 
The major epicardial coronary vessels 
act primarily as conductance vessels, 
and in the absence of atherosclerotic 
stenoses, they offer little or no resist­
ance to myocardial flow. Small intra-
myocardial arteries (penetrating the 
myocardium approximately at right 
angles) and arterioles (with a size of 10-
140 |im in diameter - below the resolu­
tion of coronary angiography) are the 
major source of coronary vascular 
resistance, together with the somewhat 
larger (100-250|.im) pre-arteriolar 
arteries. These vessels have well-
developed media, and with increasing 
vascular tone they profoundly alter the 
resistance to coronary blood flow. 
The coronary circulation is under 
neural regulation with sympathetic 
innervation (from superior, middle, and 
inferior ganglia and the thoracic sym­
pathetic ganglia I-1V), and from para­
sympathetic tone via branches of the 
vagus nerve. Specifically, the sym­
pathetic tone plays a role in vaso-
regulation of the heart, but metabolic 
autoregulation overrides, for example, 
the constrictive effect of nor-epinephrine 
(McRaven et al 1971). 
Coronary flow reserve 
Coronary flow reserve is the ratio 
between maximum blood flow during 
hyperaemia and blood flow during 
autoregulation. (Fig 1). 
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CORONARY PRESSURE 
Figure 1 Steady-state relationship between 
coronary flow and coronary arterial 
pressure in the left ventricle. The solid line 
depicts the normal relationship. At a 
constant level of myocardial metabolic 
demand, coronary flow is maintained 
constant over a wide range of coronary 
pressure, between the bounds of maximum 
coronary vasodilatation and constriction 
(dashed lines). The solid circle represents 
the normal operating point under basal 
conditions: the solid triangle is the flow 
observed at the same pressure during 
maximum vasodilatation. Flow reserve, the 
ratio of flow during vasodilatation to that 
measured before vasodilation, is in this case 
5.0 PR A = right atrial pressure: PI=o = "back 
pressure" opposing coronary flow. 
Klocke; Circulation:1987;:76:l 184 
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Flow Reserve 
Maximum 
Vasodilation 
Autoreguiatory 
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Maximum 
Vasoconstriction 
RA 
The dynamic alterations in arteriolar 
vascular tone in response to the oxygen 
demand of the myocardium, is the 
fundamental principle behind auto-
regulation. When there is a lumen-
narrowing lesion in the large epicardial 
vessels which affects coronary flow, 
autoregulatory influences alter arterial 
resistance to maintain an appropriate 
relation between myocardial oxygen 
demand and coronary flow. Once the 
vasodilator reserve capacity of the 
arterioles is reached, flow can no longer 
increase (unless the driving pressure 
increases), and the resistance of the 
epicardial vessels becomes flow-limiting 
(Mates et al 1978). 
Hence, pO2 may be the initial meta­
bolic stimulus for autoregulation, the 
following cascades of action is more 
complex. 
Several different mechanisms and 
pathways have been investigated. 
Among others adenosine (Schräder et al 
1977), prostaglandins (Moretti et al 1978) 
and potassium (Olsson et al 1987) have 
been suggested as mediators, and 
during the last years an increased 
appreciation for the role of the vascular 
endothelium has developed. 
Since the pioneer observations by 
Opherk and co-workers (Opherk et al 
1981), there are confirmations in several 
studies that patients with syndrome X 
exhibit a. reduced coronary flow reserve 
(Table 1). It is important to highlight 
that the investigated subjects have been 
very heterogeneous in the different 
trials. 
Far from all investigators use the 
classical definition based on objective 
signs of ischemia. Opherk characterised 
patients as syndrome X if they had 
"typical stress-induced angina pectoris 
promptly relieved by nitro-glycerine". 
Only 12 of 21 experienced a positive 
exercise test. In their now classical work, 
Cannon and co-workers (Cannon et al 
1985) evaluated 50 patients with "chest 
pain syndromes but with normal epi­
cardial coronary arteries". Only two had 
a positive exercise test. During atrial 
pacing 24 subject experienced chest pain 
and this group of patients were found to 
have a significant reduction in coronary 
flow reserve, compared to the subjects 
who did not report pain. Because of the 
assumption that the increased coronary 
resistance originated from vessels 
smaller than the resolution of coronary 
angiography, the term "microvascular 
angina" was introduced to denote this 
syndrome. These and later observations 
emphasise that a cardiac origin of chest 
pain cannot be excluded in patients who 
fail to develop ECG changes during 
exercise test. 
A weakness in invasive investigations 
is the problem of finding an adequate 
control group. Due to the invasive 
nature of trials concerning coronary 
flow, it is impossible to include healthy 
subjects, and control patients have often 
experienced symptoms justifying a 
diagnostic coronary angiogram. 
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Tabïe 1 Myocardial blood flow reserve in patients with syndrome X and controls 
Author Method Provocation Patients Flow Reserve 
Opherk 1981 Argon washout Dipyridamole 
intravenous 
Geltman 1990 PET Oxygen-15- Dipyridamole 
labelled water intravenous 
Galassi 1993 PET Oxygen-15- Dipyridamole 
labelled water intravenous 
Camici 1990 PET Nitrogen-13- Dipyridamole 
labelled ammonia intravenous 
Cannon 1985 Coronary sinus Atrial pacing 
thermodilution 
Greenberg 1987 Coronary sinus Atrial pacing 
thermodilution 
Camici 1991 Coronary sinus Atrial pacing 
thermodilution 
Chauan 1994 Intracoronary Papaverin 
doppler intracoronary 
21 SX (12+ET) 2.0 
15 Control 
10 CAD 
17 SX (4+ET) 
16 controls 
13 SX (13+ET) 
7 Control 
8 CAD (1-VD) 
22 SX (22+ET) 
15 Control 
24 SX* (2+ET) 
26 Control* 
10 SX** 
17 control** 
15 SX (15+ET) 
10 Control 
53 SX (53+ET) 
26 Control 
3.8 
1.9 
1.4 
3.7 
2.4 
3.9 
3.2 normal vessel 
1.7 stenotic vessel 
2.0 
2.9 
1.4 
1.8 
1.5 
1.8 
1.6 
2.0 
2.7 
5.2 
PET = Positron Emission Tomography 
Flow reserve = Maximal flow induced divided by basal flow 
SX = Syndrome X (in this table the authors study group. Different definitions - not necessarily 
including positive exercise test) 
* Patients were grouped whether they experienced chest pain during pacing (SX) or not (Control). 
** Patients were grouped whether they produced lactate during pacing (SX) or not (Control) 
+ET = Positive exercise test 
CAD = Coronary artery disease 
1-VD = One-vessel disease 
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Pathophysiology behind reduced 
coronary flow reserve-Hypotheses 
It is still unknown whether the nature of 
increased vascular resistance is 
structural (vascular wall hypertrophy) 
or functional (vasoconstriction or lack of 
vasodilatation), but interesting theories 
have been presented regarding possible 
mechanisms. 
Pre-arteriolar coronary constriction. 
The proximal compartment of resistive 
vessels are the prearterioles, the distal 
compartments are composed of the 
arterioles. The arterioles vasomotor tone 
is influenced mainly by autoregulation, 
but pre-arterioles whose main purpose 
is to maintain an optimal perfusion 
pressure at the origin of the arterioles, 
are regulated by both neural, hormonal 
and local vasoactive factors. 
It is impossible to exactly determine 
the site (arteriole or pre-arteriole) 
responsible for an increased coronary 
resistance with methods currently 
available. A theoretical concept, based 
on observations that dipyridamole 
induces pain and ischemia in the 
presence of increased myocardial flow, 
may provide insight into this issue 
(Epstein et al 1986). The localisation of 
flow impediment must, in this model, be 
located in the small pre-arteriolar 
vessels prior to the branching point of 
the subepicardial arterioles, to induce 
coronary transmural blood flow steal 
from the subendocardial region. 
A more general model has been 
proposed by Maseri (1991). He sug­
gested that there is a patchy distribution 
of abnormal constriction of pre-arterioli 
vessels. An increased resistance in these 
vessels can explain the reduced coronary 
vasodilative response observed, even 
when the small arterioles are supposed 
to dilate maximally. A localised com­
pensatory increase of adenosine release 
can cause angina even in the absence of 
ischemia, since adenosine, except for 
being a potent vasodilator, also has 
algogenic properties and is even 
considered to be the mediator of p ain in 
angina pectoris (Sylvén et al 1986). The 
speculation of patchy distribution of 
impaired coronary flow reserve was 
confirmed in a study employing PET 
(Positron Emission Tomography) and 
15-oxygen-labelled water (Galassi et al 
1993). Patients with syndrome X had 
higher resting perfusion than both 
normal subjects and patients with one-
vessel disease. After dipyridamole 
infusion small areas of hypoperfusion 
were irregularly distributed in all 
anatomic regions, whereas in patients 
with coronary artery disease, the hypo-
perfused areas were clustered in the 
region supplied by the stenotic artery. 
Neurohumoral control 
There are studies indicating that patients 
with syndrome X may have increased 
sympathetic activity, since they have 
been found to have a higher mean heart 
rate (Galassi et al 1991), an increased 
coronary artery tone and higher plasma 
levels of cathecolamines during exercise 
(Ishihara et al 1990). Frebert and co­
workers found that patients with micro­
vascular angina but normal exercise 
tests, demonstrated signs of a general 
elevated sympathetic activation with a 
higher heart rate and a decreased heart 
rate variability (Frabert et al 1995). On 
the other hand the patients with micro­
vascular angina and a positive exercise 
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test did not exhibit signs of autonomic 
dysfunction. 
Endogenous peptides (i.e. Neuro-
petide Y and endothelin) may also play 
an important pathogenetic role since 
they can cause a distal vasoconstriction 
potent enough to overpower auto-
regulation (Larkin et al 1989). 
Intracoronary infusion of Neuro­
peptide Y to patients with syndrome X 
induces chest pain and ECG changes but 
no lumen changes in the epicardial 
coronary arteries (Clarke et al 1987), 
while at the same time contrast medium 
run-off is lengthened indicating con­
striction of small coronary vessels (Kaski 
1992). This implies that coronary hyper­
reactivity to constrictor neuropeptides 
may be present in patients with synd­
rome X. A finding not supporting a 
pathophysiologic impact of increased 
sympathetic tone is the lack of efficacy 
for treatment with alpha-blocking 
agents, which fails to improve exercise-
induced symptoms and ischemia if 
given to patients with syndrome X 
(Galassi et al 1989). 
Role of epicardial vessels. 
In contradiction to the general assump­
tion that the target for the impaired 
coronary flow reserve in syndrome X is 
at pre-arteriolar or arteriolar level, a 
study has been presented which ident­
ifies a subgroup of patients with a vaso­
constrictor response that involves the 
epicardial branches (Montorsi et al 1991). 
A similar result was achieved by 
Bugiardini and co-workers who found a 
constrictor response with increased 
vascular tone in the microcirculation and 
the epicardial vessels, suggesting a 
disorder involving the entire coronary 
tree (Bugiardini et al 1993). 
Endothelial dysfunction. 
The vascular endothelium lines the 
entire circulatory system. It is evident 
that the endothelium itself has a relaxing 
effect on the smooth muscle (Furchgott 
et al 1980). Many stimulus have been 
shown to induce endothelium-de-
pendent dilatation, among others endo­
genous and pharmacological agents 
such as acetylcholine, substance P and 
bradykinin, as well as mechanical 
stimuli like flow (shear stress). Furchgott 
proposed that the action was mediated 
via a substance, an "Endothelium 
Derived Relaxing Factor, EDRF". It later 
became clear that this substance was 
identical to nitric oxide, NO (Palmer et al 
1987). The research group lead by 
Moncada a year later identified the 
amino acid L-arginine as the biological 
precursor to NO (Palmer et al 1988) 
which, for conversion, is dependent on a 
family of enzymes, nitric oxide synthase, 
"NOS" (Bredt et al 1991). 
In the investigational situation acetyl­
choline has shown to be the agent best 
suited for evaluation of endothelium 
function, since it dilates the vessel in 
presence of intact endothelium, a 
response which will be reversed to 
constriction when the endothelium is 
defect. 
Theoretically an impaired endothelial 
function is a very pleasing mechanism 
behind coronary flow impedance in 
patients with syndrome X and evidence 
has been sought. 
Flow-response after acetylcholine and 
dipyridamole were measured in 23 
patients (Motz et al 1991). Eight patients 
did not show increased flow after acetyl­
choline, whereas coronary blood flow 
increased after dipyridamole. In six 
patients, neither acetylcholine nor-
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dipyridamole were followed by in­
creased flow. Interpretation of th is study 
should nevertheless be performed with 
care, since fourteen of the patients had a 
history of arterial hypertension and five 
had negative exercise test. 
Lagerqvist provoked 20 patients with 
angina pectoris, pathologic thallium 
scintigram and normal coronary angio­
graphy with intracoronary infusion of 
acetylcholine (Lagerqvist et al 1991). 
There were unfortunately no consistent 
findings in the response in this group of 
patients. 
Vrints et al infused high doses of 
acetylcholine intracoronary in 24 
patients with normal coronary angio­
grams (Vrints et al 1992). Twelve 
patients with typical angina pectoris 
responded with constriction, even more 
pronounced than in patients with docu­
mented coronary artery disease. No 
coronary flow measurements were 
made, leaving endothelial function at 
microvascular level as speculative. 
The strongest evidence for a relation­
ship between syndrome X and impaired 
endothelial function was found in a 
recent study by Egashira and co­
workers. They demonstrated, with intra­
coronary doppler measurements, 
reduced coronary flow after acetyl­
choline administration in nine patients 
with syndrome X c ompared to controls 
(Egashira et al 1993). This difference was 
not present when provocation was 
repeated with nitrate and papaverine. 
This observation is today the strongest 
evidence that endothelial function is 
abnormal in patients with syndrome X. 
Mechanisms of pain and pain 
perception 
Pain induced by cardiac ischemia can be 
regarded as a warning signal, and is 
probably generated by the stimulation 
of cardiac polymodal receptors, which 
respond to both mechanical and 
chemical stimuli. Adenosine, bradykinin 
and K+ are all considered as possible 
mediators of isc hemic pain (Sylwén et al 
1986, Maseri et al 1992). 
Following sensory receptor stimul­
ation, the nociceptive impulses are 
transmitted in slow C-fibres or the faster 
Aö-fibres. 
These fibres project on dorsal horn 
neurones that also receive impulses 
from somatic fibres in the same derma­
tome. The transmission of nociceptive 
messages is modulated in the dorsal 
horn spinal neurones according to the 
"gate theory of pain control", proposed 
by Melzack and Wall (1969). This leads 
to that nociceptive inputs from distant 
areas can inhibit the activity of the 
convergent neurones. 
The projection is transmitted from the 
dorsal horn along the spinothalamic 
tract to the thalamus. The target for the 
ascendant pathways beyond thalamus is 
cortex and the cingulate gyrus, but there 
is probably not a specific localised "pain-
centre" present. 
Following recent research, abnormal 
pain perception has been suggested as a 
mechanism behind chest pain in 
syndrome X. 
Pain is provoked in a substantially 
higher proportion of patients with 
microvascular angina compared to 
patients with coronary stenosis when 
right ventricular pacing is performed 
(Cannon et al 1990). Similarly in patients 
fulfilling the criteria for syndrome X 
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their typical chest pain was provoked by 
catheter movement within the right 
atrium and by intra-a trial boluses of 
saline (Shapiro et al 1988, Chauhan et al 
1994). 
Finally has it been reported that 
patients with syndrome X report chest 
pain on a lower dose of adenosine 
compared to healthy volunteers 
(Lagerqvist et al 1992). 
Role of estrogen 
A marked sex difference with a majority 
of males in the risk zone for developing 
coronary heart disease has long been 
recognised (Glendy et al 1930). This is in 
contradiction to syndrome X where 
there is a female predominance (Kemp et 
al 1967 and 1986). The first appearance 
of the disease is often in relation to 
menopause and a high prevalence of 
hysterosalpingo-oophorectomy has been 
noted prior to the onset of symptoms 
(Sarrel et al 1992, Rosano et al 1992). This 
has led to the assumption that estrogen-
deficiency may play an important role 
behind the pathogenesis of syndrome X. 
There is now an abundance of re­
search reporting that estrogen has 
vasodilator properties. The classical 
model of steroid action is diffusion into 
the target cell where it binds to a 
receptor, and the hormone-receptor 
complex binds to specific DNA 
sequences, resulting in altered tran­
scription of specific mRNA and sub­
sequent protein synthesis (Farhat et al 
1995). This genomic pathway can be 
detected within an hour after hormone 
administration. Estrogen also clearly 
acts with responses that are non-
genomic and these vascular effects can 
be observed within minutes or even 
seconds after administration. Jiang 
demonstrated that 17-ß-estradiol induce 
relaxation in both female and male 
rabbit coronary arteries (Jiang et al 1991), 
and they subsequently demonstrated 
that this effect was in concordance with 
calcium-blocking agents (Jiang et al 
1992). Williams reported that acute 
administration of estrogen attenuates 
the coronary vasoconstrictor response to 
acetylcholine in atherosclerotic ovari-
ectomized cynomolgus monkeys 
(Williams et al 1992), a response that 
earlier had been demonstrated with 
chronic treatment (Williams et al 1990). 
These observations suggest that estro­
gen plays a fundamental role in the 
normal regulation of vascular tone. In 
humans it has been demonstrated that 
women with early coronary disease who 
are treated with estrogen replacement 
therapy (ERT) show a vasodilator 
response to acetylcholine infusion, while 
women not receiving ERT show a 
vasoconstrictor response on acetyl­
choline. Gilligan showed that intra-
coronary infusion of p hysiological levels 
of e stradiol-17-beta prevented epicardial 
constriction induced by acetylcholin, 
leading to increased coronary flow 
(Gilligan et al 1994). 
Randomised trials have now been 
presented regarding estrogen replace­
ment therapy. Rosano et al demonstrated 
in a placebo-controlled trial with 
exercise tests in eleven female patients 
with coronary artery disease (CAD), that 
17-ß-estradiol improved time to 1mm 
ST-segment depression and total 
exercise time (Rosano et al 1993). 
In patients with syndrome X, ERT has 
been demonstrated to improve symp­
toms in form of reduced chest pain, and 
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cessation of hot flushes, as well as 
improvement of the hyperaemic 
response of post-occlusion blood flow 
(Sarrel et al 1992). This implies a possible 
relationship between estrogen deficiency 
and chest pain in at least a subset of 
women with syndrome X. 
Extracardiac manifestations 
It is not unusual that patients with 
syndrome X simultaneously demon­
strate symptoms from non-cardiac 
organs. For example, migraine headache 
and Raynaud phenomena have been 
found in a high prevalence. 
Airway hyperesponsiveness has also 
been demonstrated in patients with 
microvascular angina (Cannon et al 
1990), these findings being consistent 
with the hypothesis that syndrome X 
may represent a more generalised 
abnormality of vascular and non­
vascular smooth muscle function. This 
was first proposed when a reduced 
forearm vasodilator reserve was demon­
strated by Sax and co-workers, who 
investigated hyperaemic responses to 
forearm ischemia with plethysmography 
in 16 patients compared with normal 
controls (Sax et al 1987). 
Diabetes mellitus is most often con­
sidered as an exclusion criteria when 
investigations are performed regarding 
syndrome X. The reason for this is 
avoidance of inclusion of patients with 
structural small vessel diseases. In a 
series of eleven patients without overt 
diabetes mellitus, stimulated hyper-
insulinaemia was found (Dean et al 
1991), this was later confirmed by 
Chauhan et al 1994. Further information 
was achieved by B0tker and co-workers 
who, applying the technique of glucose 
turnover during a 2 hour hyperinsulin-
aemic clamp, found that patients with 
syndrome X had substantial insulin 
resistance (B0tker et al 1993). This 
suggests that there could be a 
connection between the "cardiologie 
syndrome X" a nd the "metabolic synd­
rome X" (=insulin resistance, hyper­
tension, hyperlipidaemi and central 
obesity). Reaven introduced this term, 
probably unaware of the existence, since 
15 years, of the "cardiologie syndrome 
X", which has led to a great deal of 
confusion. In B0tker and co-workers 
study, no other features of metabolic 
syndrome X was found, this is in 
contrast to a recent work were non-
obese men with chest pain and normal 
coronary angiogram were insulin 
resistant, hyperinsulinaemic and had 
increased levels of triglycerides (Swan et 
al 1994). 
There is by some colleagues an appre­
hension that patients with syndrome X 
are a group of hyperchondriacs and 
neurotics. This could in part be 
explained by the fact that these patients 
are often misunderstood and regarded 
as simulates when the findings of 
normal angiograms are evident. How­
ever, employing accepted research 
methods with interviews before the 
diagnostic angiograms has revealed a 
high co-existence, up to 40%, with 
psychiatric morbidity (Waxier et al 1971, 
Bass et al 1984). Anxiety neurosis is the 
most common psychiatric diagnosis and 
it is often accompanied by unexplained 
breathlessness (Bass et al 1983). These 
figures appear extremely high, but one 
should keep in mind that this 
association consisted of patient with 
normal coronary arteries and objective 
signs of ischemia were not required. In 
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comparison 23% of patients with 
coronary artery disease (Bass et al 1984) 
and 27% of patients in general medical 
clinics (Davies 1964) have also signs of 
psychiatric morbidity. 
Differential diagnosis 
A complete history is usually important 
in the search for the correct diagnosis. 
There are some clinical characteristics 
typical for syndrome X, for example 
pain at rest, general fatigue, dyspnea 
and prolonged pain, often >30 minutes 
in duration (Kaski 1994). Still, it is 
important to rule out other diagnosis 
before the patient can be regarded as 
having syndrome X. 
Cardiac Chest Pain 
Spasm angina has some features in 
common with syndrome X, and efforts 
should be made to rule this out since 
spasm angina is a different disease with 
a different pathogenetic background, 
and show often a good response to 
pharmacological treatment (calcium 
channel blockers and nitroglycerine). 
There are possibilities that spasm can co­
exist with syndrome X but in patients 
with "angina-like pain" only 5% had 
signs of sp asm (Heupler et al 1973), and 
4 of 58 patients with exercise induced 
angina, normal coronary arteries and a 
high proportion of lactate production, 
responded with spasm on methergine 
provocation (Bertrand et al 1982). 
It is often wise to include an echo­
cardiography in the arsenal of investi­
gative analysis of angina and normal 
coronary angiogram, since it can reveal 
heart conditions often associated with 
chest pain e.g. aortic regurgitation, 
aortic stenosis, mitral valve prolapse, 
hypertrophic cardiomyopathy and 
dilated cardiomyopathy (Nitenberg et al 
1988, Cannon et al 1985, Opherk et al 
1983). 
Non-cardiac chest pain 
In some clinical reviews >50% of 
patients with chest pain with normal 
coronary arteriograms are believed to 
have symptoms that originate from the 
musculoskeletal system (Urschel et al 
1973), but since this is very common 
even in the general population it could 
simply be an innocent bystander. 
Pain arising from the oesophagus is 
clinically often difficult to differentiate 
from pain of cardiac origin. Abnormal 
refluxes have been found in a high 
proportion of patients with chest pain 
and normal coronary arteries. 
(DeMeester et al 1982). Another ex­
planation could be elevated distal oeso­
phageal pressure with normal peristaltic 
consistent with "nutcracker oesophagus" 
(Richter et al 1988). 
A complicating factor is that oeso­
phageal dysfunction and coronary heart 
disease often co-exist. It is possible that 
there is even a link between the two 
conditions, "linked angina". Oeso­
phageal acid stimulation has been 
demonstrated to reduce coronary blood-
flow in syndrome X, suggesting the 
presence of a cardio-oesophageal reflex 
(Chauan et al 1993). This implies that 
oesophageal reflux really can induce 
angina pectoris! 
Other conditions that can mimic 
angina pectoris are peptic ulceration and 
gall bladder pain (Hamton et al 1959). 
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Treatment 
Patients with syndrome X are con­
sidered to respond poorly to con­
ventional pharmacological treatment. 
There are different regimens which have 
been tried and found effective, and some 
studies are presented below. 
Sublingual nitrates are effective in 
relieving chest pain in approximately 
50-60% of the patients (Kemp et al 1973, 
Romeo et al 1993). 
Treatment with alpha-blocking agents 
(prazosin or Clonidin) have been given 
in an attempt to reduce alpha-adrenergic 
stimulation to the micro-circulation 
(Galassi et al 1989). No significant 
changes were seen in exercise duration, 
heart rate-blood pressure product or ST-
segment shift on ECG. 
Imipramin has been shown to reduce 
the frequency of anginal attacks 
(Cannon et al 1993). The authors believe 
this to be related to the drugs' visceral 
analgetic effect, and not to the anti-
depressive effect. 
The adenosine inhibitor, theophylline 
has been demonstrated to improve 
exercise capacity in patients with 
ischemic heart disease (Créa et al 1989). 
This has also been repeated in patients 
with syndrome X were intravenous 
infusion of aminophylline in eight 
patients abolished the ECG changes and 
increased effort tolerance in presence of 
an increase in rate-pressure product 
(Emdin et al 1989). 
The ACE-inhibitor enalapril has also 
been tried in syndrome X (Kaski et al 
1994). Ten patients with syndrome X 
and a reduced coronary flow reserve 
underwent exercise tests after two 
weeks of treatment with enalapril 
10mg/day or placebo. Total exercise 
duration and time to angina was 
prolonged, and magnitude of ST 
segment depression was decreased 
during active treatment. The authors 
speculate that the effect is mediated by a 
direct modulation of microvascular tone, 
resulting in an increased myocardial 
oxygen supply. 
In a double-blind placebo-controlled 
trial, consumption of nitroglycerin was 
reduced and exercise duration was 
prolonged after one month of treatment 
with verapamil or nifedipin (Cannon et 
al 1985). However, there were no 
differences in ECG-changes or in rate-
pressure product. 
Betablocking agents has been com­
pared to calcium channel blockers 
(verapamil vs acebutolol). In fifteen 
patients verapamil were superior to 
both placebo and acebutalol, and in the 
remaining fifteen both verapamil and 
acebutolol revealed a significant pro­
longed exercise duration (Romeo et al 
1988). 
In our personal experience the 
beneficial effect of pharmacological 
administration is not always maintained 
during long-term treatment, but in the 
clinical situation we often start with 
calcium channel blockers and short 
acting nitroglycerin, and when in­
effective, other regimens are prescribed 
in a "trial and error" way. 
Prognosis 
Long-term follow up studies have 
shown an excellent outcome regarding 
cardiac death and myocardial infarction 
in patients with chest pain and a normal 
coronary angiogram (Table 2). 
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Table 2 Outcome of patients with angina and normal or near-normal coronary angiogram 
in different trials 
Author No of Mean follow-up Population Non-fatal Mortality 
patients (months) (degree of myocardial Cardiac Total 
stenoses) infarction (%) 
Waxier 1971 86 15 N 0 0 0 
Kemp 1973 200 36 <10% 0 2 3 
Bemiller 1973 37 49 N 0 2.7 2.7 
Bruschke 1973 342 60-88 N 0.9 0.6 5.2 
101 <30% 4 4 -
57 30-50% 3.5 5.3 
-
Pasternack 1980 159 43 0-30% 0.6 0 0 
Proudfit 1980 357 120 N 0.8 0.8 _ 
101 <30% 7.9 2 6.4 
63 30-50% 6.3 15 16.5 
Ockene1980 57 16 N 0 0 0 
Kemp 1986 3136 84 N 
-
0.4 1.3 
915 <50% 
-
1.9 4.8 
Papanicolau 1986 1491 60 0-25% 1 - 2 
486 25-50% 3 
-
2 
Romeo 1993 30 60 N 0 0 0 
Radici 1995 30 146 N 0 0 3.3 
Lichtlen 1995 176 147 N 2.3 1.1 2.3 
Kaski 1995 99 84 N 0 0 0 
* = Cardiac death includes sudden death of unknown reason 
- = Data not available in article 
N = Completely normal angiogram 
23 Per Albertsson 
Hence, there seems to be reasons to 
differentiate between patients with mild 
disease and patients with completely 
normal angiograms. Bruschke demons­
trated that patients with entirely normal 
angio-grams had an incidence of 
myocardial infarction and cardiac death 
of only 0.9% and 0.6%, respectively, 
during a 5-year follow-up period 
(Bruschke et al 1973). In the presence of 
mild disease the incidence of myocardial 
infarction increased to 5.3% and cardiac 
death to 3.5%. A similar result was 
found by Proudfit, with cardiac 
mortality being 0.6% with normal 
angiography, increasing to 1.9% in the 
presence of <30% stenosis, and 15.9% in 
patients with 30-50% stenosis during a 
10-year follow-up period (Proudfit et al 
1980). 
It seems moreover reasonable to 
believe that the two groups constitute at 
least two different populations, 
probably with different mechanisms 
behind the pain. 
In spite of the good prognosis 
regarding mortality and risk for 
development of myocardial infarction, a 
high proportion of the patients continue 
to have chest pain, which has been 
described in a frequency of 20-80% 
(Kemp et al 1973, Proudfit et al 1980, 
Bemiller et al 1973, Isner et al 1981). Once 
again the discrepancy between trials can 
be explained by different populations 
being investigated. 
A subgroup with a worse prognosis 
may be patients with constant or rate-
dependent left bundle branch block. In 
this subgroup, a deterioration in left 
ventricular function has been described, 
with an increase in exercise pulmonary 
artery pressure and a decrease in 
ejection fraction (both at rest and during 
exercise) when these investigations were 
repeated after four years (Opherk et al 
1989). It is possible that "syndrome X 
with left bundle branch block" may be 
an early form of dilated cardiomyopathy 
(Kiibler et al 1992). There are some 
similar features and a reduced coronary 
vasodilator capacity has also been 
described in patients with cardio­
myopathy (Opherk et al 1983). This 
reduction in the dilatory capacity is 
probably explained by hemodynamic 
alterations, e.g. increased diastolic wall 
stress, and there is no data that support 
an identical mechanism behind 
increased coronary vascular resistance 
as in syndrome X. 
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AIMS OF THE PRESENT STUDY. 
1, To asses the incidence of normal coronary angiogram in a population performing 
coronary angiogram. 
2. To study the morbidity in terms of demographic background data and utilisation of 
medical resources in patients with normal and near normal coronary angiogram. 
3. To asses self-estimated "quality of life" among patients with chest pain and normal or 
near normal coronary angiograms. 
4. To study the coronary hemodynamic patterns in patients with syndrome X. 
5. To study myocardial metabolism and evidence for ischemia during atrial pacing and 
adenosine administration in patients with syndrome X. 
6. To explore the value of a new non-invasive method in the diagnosis of syndrome X. 
7. To evaluate the endothelium dependent and independent flow response in the 
peripheral circulation in syndrome X. 
8. To examine the value of estrogen replacement treatment to postmenopausal women 
with syndrome X. 
9. To examine the value of Spinal Cord Stimulation in patients with syndrome X. 
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METHODS 
Study designs 
Paper I and Paper II. 
In these papers an open prospective 
design was employed to register all 
patients who performed coronary 
angiography during the period May 88 -
May 91. Estimation of hospitalisation 
and utilisation of medical resources 
were performed in a retrospective 
analysis in Paper I. 
Paper III. 
Carefully selected patients with chest 
pain and and normal coronary 
angiogram were recruited to this open 
labelled designed trial. 
Paper IV. 
This is an open labelled designed trial 
without use of placebo where the 
influence of adenosine infusion on left 
ventricular function was studied. 
Analysis of the recorded echocardio-
graphic investigations were performed 
by two independent investigators not 
familiar with the result of the exercise 
tests. 
Paper V. 
Study 1 in Paper V is an open-designed 
trial where the study drugs were given 
in a randomised order. In Study 2 in the 
same paper a randomised placebo-
controlled cross-over design was 
employed. 
Paper VI. 
A randomised placebo-controlled cross­
over design was used in this paper. 
Paper VII. 
This is an open trial where the order of 
treatment and control exercise tests 
could not be randomised since we 
lacked knowledge of the long-term 
effects of spinal cord stimulation. 
Patients 
In Papers I and II all patients in a 
population with chest pain and a normal 
coronary angiogram were studied. The 
remaining five papers are experimental 
trials and the patients were carefully 
selected. Some patients participated in 
more than one study (See Table 3 for 
further information). In general, patients 
were recruited to the study groups 
(syndrome X) if they had typical 
exertional angina, a positive exercise test 
and a completely normal coronary 
angiogram. The chest pain was typical 
and was suspected of originating from 
an ischemic heart condition. Papers III 
and IV include control patients who had 
performed coronary angiography. 
26 Per Albertsson 
u <u 
Oh  
<tt 
P h  
c 
o 
'•S bù 
V» C0 0) 
C 
G 
v 
'"S 
eu 
X 
41 
S 
0 
'S 
1 
CD 
CO 
OJ 
r—H 
„Q 
rö 
H 
IS Z
x
3 
q 1.
0 
2.
0 1.
3 
2.
0 oo _ m n  in i n  i n  Ö  °  CN  r i  H  r l  O  
Ex
7 
W
a
tt 
10
3 
90
 
14
3 
12
0 
80
 
90
 
87
 
60
 
90
 
90
 
10
3 
90
 
Ex
6 
ST
 
0.
5 q co c t n  
t-4 Ö <N ri 2.8
 
1.
6 
2.
5 1.
9 
2.
6 1.
7 
1.
5 0
1
 C N  1.3
 
Ex
6 
W
a
tt 
80
 O
il 
08 05 06 
90
 
80
 
90
 
10
0 06 
80
 
10
0 o C T v  
O
il 
06 
Ex
4 
ST
 oo in o o o d in in 
r4 ri -di H (N |H H H q i n r i q i n q N N q q i n i n  r ^ r H r i r f t N r i i H ^ H n i ^ r -
Ex
4 
W
at
t 
14
0 
10
0 
80
 
16
0 
12
0 
40
 
14
0 
13
0 
10
0 
10
0 
11
0 
13
0 
80
 
10
0 
9 0
 
12
0 
11
0 
12
0 
14
0 
80
 
Ex
 3
 
ST
 
1.
2 
1.
4 C J > O v N H O M C O O l f i p H O v  
r i r H H r i r i f S H O i r l i - J r H  
Ex
 3
 
W
at
t 
80
 
80
 
12
0 
60
 
90
 
80
 
18
0 
90
 
70
 
12
0 
13
0 
11
0 
10
0 
# 
ES
ES
 
f* in oo in (N Z
l 01 6 9 € 1
1 f 
w 
w 
* 
r H  <N v £> en IN •rf rH t~s OO ON o cs r H  C O  •<* m 
# 
E-
Pe
rif
.
 
1
 
10
 ( N  i n  co in as \© oo 
» 1  
«  s  
1 10
 
CN N co in as vo t »< 00 
A
D
O
 
Ec
ho
 
tfl bO 1/1 ID n m ID 10 0  O I O O O O O O  P-, 2 PH P4 P * O H OH 
w u j b O w j c n w b O h n b O w w b O  0 0 < U 0 0 0 a ) a j U 0 0 Q >  
# 
Ec
ho
 
£ £ >n 2  ^ro 
# 
C
at
h.
 
T-« CN c o - ^ i n ^ o i N c o o N ^ J I J ^ J ^ Ï  I I  % 
G
en
de
r 
F F P H  P h  P h  P - P h  
a
ge
 
72
 
55
-6
0 
44
-4
5 
68
 
60
.6
4 
55
-6
1 
58
-5
9 
60
-6
3 
60
 
58
-6
0 
62
-6
7 
62
 
60
-6
1 
60
-7
1 
72
-7
4 
50
-5
4 
59
 
56
-5
8 
67
-7
1 
44
 
48
 
58
 
63
 
51
 
51
 
50
 
48
-5
1 
61
 
64
 
63
 
57
 
53
 
57
 
54
 
rH 
vO C O  in 
Su
bj.
 
M
K
 
RA
 
w ^ 2 j J l Ü Ü < ^ ^ > H D p w 2 a ( i < w I h W ^ K ! 3 ß S » 2  
M
T 
LP
 
I-L
N
 
cn 
i 
I-L
B g  
*! dl S 3 C . 2 <v I» 'H (1 fl| 
QJ rr -j U »-< 
& « £ £ 
"3 y u. 
f ä i i  
u: i < TJ H tu 
: >  >  s  
i ? Ö 11 
— 
s 8"  ^O. [2 
S.Ï 
« s ÛH Ç u 
<N £ 
 ^(j " s, 
•8 * .S g. 
Ji > 
" V  -a» *rj o 
•I 'I S. a l 
öp O O [ 
i  *  X  .  
« ;  
•
s >  
i- s 
s-g-
8 * 1 «  ( « • S h  CD 
U C OJ 
•• tî OJ D î t  v s  ^
S ""•§ ia o c 
2 &.-S 11 £ Ä 2 4 S 
«s ôi *> cx, "5 
m I O ±3 - u T3 
 ^& ii C — g 
s Hi g g s 
w  ^5 -S s 
s g»!  H 
U l l ?  &  
i  §* ! ! J  
I n n  
tu (ü « C  ^
SP .s ~ j " 
2 a JS TÎ <c 
8>| » S B u 
•SP« <, « 
• t ï "  
> .s $ i 
27 Per Albertsson 
Paper I and Paper II. 
All patients performing coronary angio­
graphy at Sahlgenska University 
Hospital, Östra University Hospital and 
Skövde Community Hospital during the 
period May 88 - May 91 were registered. 
At the time of registration these three 
centres performed all the coronary 
angiograms in western Sweden 
(population 1.5 million). Four hundred 
and twenty-one patients were excluded 
since background data and indication 
for the coronary angiogram were in­
completely registered. Patients who had 
previously performed CABG (n=280) or 
PTCA (n=182) were also excluded as 
were patients with concomitant valvular 
disease (n=636) and patients with 
indications other than angina pectoris 
being the indication for angiography, 
e.g. arrhythmias, congestive heart 
failure, cardiac tumours etc. (n=424). 
The remaining population of 2639 
performed angiography due to chest 
pain suspected to originate from 
coronary artery disease and since CABG 
or PTCA had not been performed the 
presence or absence of coronary stenoses 
was not known. These patients con­
stitute the investigated population in 
Papers I and II. 
Paper III. 
Thirteen patients with syndrome X (10 
females, mean age 60 years) were 
compared with 9 patients (4 females, 
mean age 52 years) with atypical chest 
pain, negative exercise test and a normal 
coronary angiogram. The indications for 
coronary angiogram had been chest pain 
but this was atypical, the exercise tests 
were negative and the chest pain was 
not suspected to originate from an 
ischemic heart condition. 
Paper IV. 
20 patients (11 women) with syndrome 
X constituted the study group. Mean age 
was 56 years. They were compared with 
two separate control groups. One 
consisted of 17 patients (11 women) with 
atypical chest pain, negative exercise test 
and a normal coronary angiogram. 
A second control group consisted of 
10 completely healthy males who had 
not performed coronary angiogram. 
Their mean age was 29 years. 
PaperV. 
This paper is based on two studies. The 
first study included 10 patients with 
syndrome X (5 females) with a mean age 
of 60 years and 9 healthy controls (5 
females) with a mean age of 55 years. 
The second study included 11 post­
menopausal women with syndrome X, 
mean age 59 years and the control group 
constituted of 8 postmenopausal healthy 
women with a mean age of 58 years. 
Paper VI. 
15 natural postmenopausal women with 
syndrome X with a mean age of 58 years 
were compared with eight healthy post­
menopausal women with a mean age of 
58 years (same control group as in Paper 
V, Study 2). 
Paper VII. 
Twelve patients (eight females) with 
exercise induced chest pain, positive 
exercise test and a normal coronary 
angiogram with a mean age of 61 years 
were studied. They had all been treated 
with spinal cord stimulation (for a mean 
time of eight month) and responded 
well to the treatment. 
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Estimation of hospitalisation 
All patients with insignificant coronary 
artery stenoses in Paper I were 
approached with a questionnaire more 
than two years after the diagnostic 
angiogram, asking if and where they 
had been hospitalised during four years 
(two years prior to and two years after 
the diagnostic angiogram). Furthermore 
all medical files from all 15 hospitals in 
western Sweden were collected. The 
main diagnosis given at each time of 
hospitalisation is presented in the 
analysis. 
Quality of Life 
Questionnaires for self-administration of 
quality of life were mailed to all patients 
before the diagnostic coronary angio­
gram in Paper II. Three different 
questionnaires were completed by the 
patients; the Physical Activity Score, the 
Nottingham Health Profile and the 
Psychological General Well Being Index. 
The Physical Ac tivity Score contains six 
questions, an extract from an angina-
specific questionnaire, (Angina Pectoris 
Quality of Life Questionnaire), for self-
estimation of physical abilities (Wilson et 
al 1991). Each item is graded from 1-6 
and the mean value for all items are 
calculated, the higher the total value, the 
greater is the disability. 
The Nottingham Health Profile is used 
to assess health-related Quality of Life 
(QL) and constitutes two parts where 
the respondent are expected to answer 
Yes or No (Hunt et al 1980). The first part 
includes 38 statements which reflects 
limitations of activity or aspects of 
distress in six separate dimensions: 
physical mobility, energy, pain, sleep, 
social isolation and emotional reactions. 
A total score of 100 can be obtained from 
each dimension, the higher the score -
the greater limitation of activity or level 
of distress. The second part reflects 
seven aspects of social life that is related 
to the patients state of health; 
occupation, ability to perform tasks 
around the house, social life, home 
relationships, sexual life, hobbies and 
holidays. 
The Psychological General Well Being 
Index constitutes 22 questions, dealing 
with six different aspects of well-being; 
anxiety, depression, vitality, general 
health, self-control and well-being (16). 
A score from 1-6 should be given for 
each item, giving a total score rate of 22-
132, with the highest score corres­
ponding to superior well-being. 
Exercise tests 
All tests were performed on bicycle and 
a 12-lead ECG was recorded according 
to standardised technique. 
In Papers I and II all subjects but one 
had undergone exercise tests. The tests 
were analysed retrospectively. 
The exercise tests in Papers III-VII 
were performed prospectively on an 
automatically braked bicycle (Corival 
400 LODE, Groningen, The Netherlands, 
Papers V and VI or Rodby, Siemens 
Elema, Solna, Sweden, Papers III, IV and 
VII). The ST-segment depression 60ms 
after the J-point in the lead showing 
most change from, baseline was 
measured after signal-averaging with 
use of a computer-assisted system (Case 
15 Marquette, Milwaukee, Wis USA, 
Papers III-VI) or analysed "manually" 
with a conventional system (Marquette 
Mac 1, Milwaukee, Wis USA, Paper VII). 
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The repeated exercise tests in Paper 
VI and in Paper VII were performed on 
the same bicycle, during equal 
conditions at the same time of day. 
Rapid atrial pacing 
Atrial pacing was performed via a 
coronary sinus thermodilution catheter 
(Paper III). Pacing was initiated at a 
heart rate of 100 bpm, increasing with 10 
bpm every second minute to a target 
heart rate of 160. Premature termination 
of pa cing was allowed if chest pain rated 
at least 5 on the ten grade Borg-scale 
(Borg 1982). 
Blood sample analysis 
In Paper III, blood oxygen saturation 
was determined with an OSM 2 
Hemoximeter (Radiometer, Copen­
hagen, Denmark). Oxygen consumption 
(MVO2) was computed as; (arterial-
coronary simis O2 content) x coronary blood 
flow. 
Lactic acid concentration was assayed 
by enzymatic method (Lactate Analyser 
640, Roche Bio Electronics, Basle, 
Switzerland). Myocardial lactate extract­
ion ratio was computed as; 100(arterial-
coronary sinus lactate concentration)/ 
arterial lactate concentration. 
Serum estradiol in Papers V and VI 
was assessed by radioimmunoassay 
(The Abbot Imx® Estradiol Assay, 
Diagnostic Division Abbot Park, USA). 
Nitrate, the main metabolite of nitric 
oxide was analysed using gas chromato­
graphy and mass spectrometry 
(Wennmalm et al 1993) 
Coronary sinus flow measurements 
A thermodilution catheter (Wilton-
Webster Laboratory, Altadena, Ca. 
USA) was introduced into the right 
atrium via the right internal jugular 
vein. The great cardiac vein was 
cannulated and position was verified 
with contrast injection. The position was 
kept constant in relation to "bony" 
landmarks. Coronary sinus blood flow 
was deter-mined by the continuous 
infusion thermodilution method with 
the catheter attached to a Wheatstone 
bridge. Changes in resistance were 
recorded on a Siemens-Elema Mingo-
graph (Siemens-Elema, Solna, Sweden), 
and coronary sinus blood flow (CSF) 
was calculated according to the formula; 
CSF=FIx k f(TB-TI/TB-TM)-l] where FI= 
infusion rate, TB= temperature of blood, 
TI- temperature of injectate and TM= 
temperature of mixture of blood and 
injectate, and k = a constant derived 
from the density and specific heat of 
saline solution and blood. 
Adenosine provocation 
In the first four patients in Paper III, 
adenosine 11.3 mmol/1 (3.0mg/ml; 
Hässle AB, Mölndal, Sweden) was 
given as a continuous infusion in the 
right atrium, starting with a dose of 
50|xg/kg Bw/min, increasing with 
10fxg/kg every second minute to a 
maximal dose of 100(ig/kg. In the 
remaining 18 subjects adenosine was 
administered as an intracoronary bolus 
in the left coronary ostium. The starting 
dose was 0.1 mg and thereafter 0.3, 0.6, 
1.2, 3.0, and 6.0 mg were given at two 
minutes intervals if d ose increment was 
tolerated. 
In Paper IV adenosine was given as 
an intravenous infusion with a starting 
dose of 60|ig/kg bw/ min to a maximal 
dose of 200}ig/kg/min. 
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Cardiac echocardiographic examination 
Cardiac echocardiography was 
performed with a Hewlett Packard 
Ultrasound Computerised Sonographic 
equipment with a 3.5 MHz sector 
transducer. Total ejection fraction was 
calculated from 2 and 4 chamber view 
using single plane ellipse formula (SP­
EL). Wall motion was analysed in a 9-
segment model and the segments were 
as follows: apex, proximal anterior, 
distal anterior, proximal lateral, distal 
lateral, proximal posterior, lateral 
posterior, proximal septal and distal 
septal wall. Wall motion was interpreted 
visually and graded as follows: 1= 
normal, 2=hypokinesia, 3=akinesia, 
4=dyskinesia. A total sum of 9 
represents normal function and higher 
sum implies dysfunction. To interpret 
the test as clearly positive an increase 
from rest to provocation in a total sum 
of at least 3 was required. LVSI (Left 
Ventricular Score Index) was calculated 
as total score divided by number of 
analysed segments, and an increase of at 
least 0.3 was regarded as positive. 
Estimation of forearm endothelial 
function 
An intra-arterial catheter was inserted 
into the left brachial artery. Forearm 
blood-flow was measured in the left arm 
with venous occlusion plethysmography 
(strain-gauge). An infusion of either 
acetylcholine (10, 20, 30, 40, 50, and 60 
|ig/kg/min) or sodium nitro-prusside 
(1, 2, 3, 4, 5 and 6 jig/kg/min) was 
administered in a random order. Each 
drug was infused for 4 minutes per dose 
phase with measurements taken of 
blood flow during the final minute. In 
another study design, high resolution 
ultrasound (7.0 mHz transducer and a 
128XP/10 system, Acuson, Mountain 
View, Ca. USA) was used for measure­
ment of the diameter of the right 
brachial artery during resting situation 
and following reactive hyperaemia. This 
was induced by inflation of a pneumatic 
tourniquet to a pressure of 240-250 
mmHg for five minutes. 
Spinal Cord Stimulation 
The stimulation equipment (Medtronic, 
Minneapolis, Min. USA) was surgically 
implanted under local anaesthesia. An 
electrode tip was placed epiduraliy in 
mid-line at level Th 1- Th 2. The system 
was tested and adjusted so that paraes-
thesiae covered the area of the anginal 
pain. The generator was placed in a 
subcutaneous pouch below the left 
costal arch and a connection-lead was 
tunnulated to the stimulation electrode. 
The pulse generator is controlled with 
an external magnet, and the patients are 
able to turn it on and off. In Paper VII 
the stimulation was initiated 15 minutes 
before exercise tests #4 and #5, and 
maintained during exercise and 
recovery. The last 15 seconds of every 
minute, the system was turned off to 
avoid interference with the ECG. 
Statistics 
For comparisons between groups in 
Papers 1 and 2 Fischers exact test was 
used for dichotomous variables and 
Wilcoxon's rank sum test for continuous 
or ordinal variables. In Paper I the Sign 
test was used to test for differences of 
proportions prior to and after angio­
graphy. For number of days in hospital 
Wilcoxon's signed rank test was used. A 
stratum adjusted Kruskal-Wallis test, 
using the Cochran-Mantel-Haenszel 
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statistic was used for comparison of 
quality of life scores when adjusting for 
differences for sex and age in Paper II. In 
Paper III Fisher's permutation test was 
used to test for differences between 
groups. Data before and after 
provocation were compared using 
analysis of variance (ANOVA) in Paper 
IV. 
In Study 1 in Paper V the correlation 
coefficient (Spearman rank order 
correlation) between the doses of drugs 
and the resulting flow was calculated 
separately in each subject. The resulting 
correlation coefficients for either drug 
were then compared between groups 
using the non-parametric Mann-
Whitney U test. In Study 2 in Paper V 
Student's f-test for paired or unpaired 
data was used. Also in Paper VI 
Student's f-test was carried out to 
compare placebo versus estradiol 
treatment. In Paper VII Fisher's non-
parametric test for paired comparison 
(Bradley) with two-sided test was 
carried out. 
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RESULTS 
Paper I 
Of 2639 patients performing coronary 
angiography, 163 (6%) were found to 
have normal (n=l 13) or near normal 
(n=50) coronary angiogram. They were 
compared to patients with significant 
coronary artery stenoses, younger and 
more likely to be female (50 vs 20%). 
Patients with coronary artery stenoses 
suffered more often from previous 
myocardial infarction, congestive heart 
failure, cerebrovascular disease and 
were more likely to be diabetic. 
Sixtysix percent of the patients with 
normal or near normal coronary 
angiograms had been hospitalised 
during two years prior to the diagnostic 
angiography compared to 35% during 
two years after (Fig 1:1). 
The reduction of u tilisation of medical 
resources was mainly due to curtailed 
hospitalisation for cardiac reasons, 
which was reduced from 6.6 days to 2.8 
days in hospital (p<0.001). 
Figure 1:1 Percentage of patients with normal or near normal coronary angiogram 
requiring hospitalisation during two years prior to and two years after angiography. 
1 0 0  T  
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During two years after angiography 
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Paper II 
Approx. 85-86% of the patients with 
normal or near normal coronary 
angiogram responded to the different 
questionnaires regarding self-estimated 
Quality of Life (QoL). The corresponding 
number in the group with significant 
coronary artery stenoses was 70-72%. 
Unexpectedly, patients with coronary 
artery stenoses reported superior quality 
of life even when adjusted for sex and 
age. This was apparent in both the 
Nottingham Health Profile (NHP) and 
the Psychological General Well Being 
Index (PGWB) Fig. 11:1 and Fig. 11:11. 
The lower QoL in patients without 
significant stenoses included the NHP 
subscales concerning energy (p<0.0001), 
pain (p<0.001), mobility (p<0.001) sleep 
(p<0.001) and emotions (p<0.05). 
Regarding PGWB, patients with normal 
or near normal coronary angiograms 
reported inferior QoL in subscales 
related to vitality (p<0.0001), anxiety 
(p<0.05) and well-being (p<0.()5). There 
were however no significant difference 
in score of the more angina-specific 
questionnaire Physical Activity Score. 
With regards to patients without 
significant stenoses there were no major 
differences between patients with mild 
(<50%) stenoses and completely normal 
angiogram. There where also very 
similar scores when comparing patients 
with positive and negative exercise tests. 
Figure 11:1 Score on Nottingham Health Profile I (mean + SEM) in patients with 
coronary artery disease and normal or near normal coronary arteries. 
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Figure II:II Psychological General Well-Being Index. Total score (mean + SEM). 
A higher score indicates superior well-being. 
Hi >50% stenoses 
i—i No significant stenoses 
•• Mean value in a healthy population 
* = P<0.05 
Table 11:1 NHP I, PGWB and PAS. Comparison between patients with completely 
normal angiogram and mild stenoses, and comparison between patients with positive 
and negative exercise tests. 
Mild 
stenoses 
(n=50) 
No stenoses 
(n=113) P 
Positive 
exercise test 
(n=78) 
Negative exercise 
test 
(n=84) 
P 
NHP I 28 30 NS 28 31 NS 
PGWB 86 83 NS 85 83 NS 
PAS 4.2 4.1 NS 4.2 4.1 NS 
NHP I = Total Score in Nottingham Health Profile 1 
PGWB = Total score in Psychological General Weil-Being Index 
PAS = Physical Activity Score. 
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Paper III 
During atrial pacing an insignificantly 
higher heart rate was achieved in control 
patients compared to patients with 
syndrome X. Pa tients with syndrome X 
reported more severe chest pain and 
they also demonstrated more pro­
nounced ST-segment depression. The 
baseline coronary flow was higher in 
patients with syndrome X, but the 
relative flow increase on maximal atrial 
pacing was higher among controls, 
which was in contradiction to flow 
increase after adenosine administration 
which was equally high in the two 
groups (Fig. III:I). 
Ergonovine administration was not 
accompanied by differences in coronary 
flow changes in any of the two groups. 
ECG changes and pain reaction was 
similar in patients with syndrome X and 
in controls. 
Myocardial lactate extraction was 
lower during pacing in patients with 
syndrome X but the difference was not 
significant. Lactate production was 
achieved in four patients with syndrome 
X during atrial pacing but in none in the 
control group. On the other hand lactate 
production was demonstrated in two 
control patients after adenosine adminis­
tration and in one patient with synd­
rome X. There were no significant 
differences in arterio venous oxygen 
difference after pacing, adenosine, or 
ergonovine provocation when com­
paring control patients and subjects with 
syndrome X. T here was a lower MVO2 
during rest in patients with syndrome X, 
but in spite of a reduced flow reserve, 
and a higher incidence of lactate 
production during atrial pacing, there 
was no differences in MVO2 during 
atrial pacing 
Figure ni:I Coronary flow increase after pacing and intracoronary adenosine 
0 Syndrome X 
Controls 
p<0.001 3.5 •• 
NS 
Flow Increase 
Pacing 
Flow Reserve 
Adenosine 
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Table III:I Myocardial Lactate Extraction 
Patient No. Rest Pacing Rest Adenosine Rest Ergonovine 
1 16,5 -7,1 16,9 1,6 
2 8,3 11,3 12,9 8,5 
3 27,4 24,6 12,7 -4,3 16,1 
4 21,2 7,7 
5 1,6 -7,9 3 4,7 6,1 4,9 
6 2,1 7,8 5 9,1 
7 
ß 
53,2 5,8 8,5 32,8 10,2 36,7 
O 
9 20 -4,3 
10 2,3 4,5 10,9 8 12,5 25,5 
11 41,5 -3,1 13,2 15 13,9 
12 
13 25 10 
mean ± SD 20±17 4+10 11±4 ** 9+12 8±4 17±11 
14 
15 31,5 7,9 17,1 20 
16 14,5 25,9 20,8 3,4 9,3 35,8 
17 32,7 10,9 23,9 -4,3 17 34,7 
18 8,2 11,3 
19 28,8 35,5 34,4 18,1 22,8 28,6 
20 11,1 
21 4,7 10,7 16,7 -5,6 5,4 24,2 
22 0 0 -7,5 -5,8 
mean ± SD 17±14 14±11 24±8 *» 3±11 11±11 23+15 
** = p<0,01 syndrome X versus controls 
Lactate extraction = myocardial lactate extraction ratio. indicates lactate production 
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Paper IV 
After adenosine provocation both 
patients with syndrome X a nd patients 
with atypical chest pain and normal 
exercise tests demonstrated a higher 
heart rate compared to healthy controls. 
There was also differences in diastolic 
blood pressure after provocation which 
was also lower in healthy subjects. 
During adenosine provocation four 
patients with syndrome X demons­
trated significant ST-depression 
compared to only one subject with 
typical chest pain and none of the 
healthy controls. 
Three of ten healthy controls, on the 
other hand, developed AV-block II or III 
which forced the infusion to be haltered 
(which resulted in a normal conduction 
in 10,13 and 25 seconds respectively). 
During adenosine infusion, 14 of 20 
patients demonstrated signs of signifi­
cant aggravation of left ventricular 
dysfunction compared to only 4 of 17 
patients with atypical chest pain and 
none of the healthy controls (Table IV:I) 
Table IV:I Echocardiographic changes during adenosine provocation 
Healthy controls Atypical chest pain Syndrome X 
LVSI rest 1,0 1,0 1,2 
LVSI adenosine 1,0 1,2 1,7* 
No of patients with 
regional dysfunction 
(score increase >3) 0 4 14* 
LVSI = Left ventricular score index 
(An increase from baseline with 0,3 or more is considered positive) 
* = p<0.05 
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Paper V 
This paper is divided into two sub-
studies. In the first study was it 
demonstrated that intra-arterial 
administration of acetylcholine resulted 
in a dose-dependent increase in forearm 
blood flow in both patients with 
syndrome X and in controls. The mean 
basal flow was 2,3 ± 0,3 and 3,0 ± 0,3 
ml/ min per 100 ml tissue, respectively. 
The flow response to the maximal dose 
of acetylcholine was in syndrome X 
patients 5,5 ± 0,8 and in controls 7,3 ± 1,8 
ml/min per 100 ml tissue, NS (Fig. V:I). 
The forearm blood flow response to the 
endothelium-mdependent vasodilator 
sodium nitroprusside was 11,2 ± 1,7 in 
syndrome X patients and 11,2 ± 1,9 
ml/min per 100 ml tissue in controls 
(NS), (Fig V:II). 
In the second study transdermal 
estrogen (estradiol 17-ß, 100|ag/24 tim) 
was shown to result in a significant 
increase in plasma estradiol levels in 
both patients with syndrome X and in 
healthy controls (from 25 ± 22 to 106 ± 49 
and from 33 ± 14 to 101 ± 55 pg/ml 
respectively). 
During treatment with placebo the 
mean resting brachial artery diameter 
was 3,34 ± 0,11 mm in patients with 
syndrome X and 3,29 ± 0,11 mm in 
controls. 
The post-occlusive diameter increased 
to 3,52 ± 0,14 mm in patients and 3,51 ± 
0,12 mm in controls (a flow mediated 
dilatation of 5,4 and 6,7 % respectively). 
Following 24 hours of transdermal 
estradiol treatment, the mean brachial 
artery diameter was, in patients with 
syndrome X, 3,23 ± 0,12 and in controls 
3,21 ± 0,06. The mean post-occlusive 
diameter increased to 3,54 ± 0,15 and 
3,58 ± 0,08, corresponding to flow-
mediated dilatation of 9,6 and 11,5% 
respectively. Estradiol treatment aug­
mented the flow-mediated dilatation of 
the brachial artery to 9.6 vs 5.4% 
compared to placebo in patients with 
syndrome X (p=0.Q26). Also in the 
placebo group the flow mediated 
dilatation was larger after estradiol 
treatment (11.5 vs. 6.7%) but this 
difference did not reach significance 
(p=0.054), (Fig V:III). However, the 
brachial artery diameter response to 
estrogen was not significantly larger for 
the syndrome X patients than that seen 
in the control group. 
Plasma nitrate levels were 53 ± 5 and 
50 ± 6 (xmol/I during placebo in patients 
and controls respectively, and were not 
significantly affected by estradiol 
treatment (55 ± 7 and 53 ± 5 jj.mol/1). 
39 Per Albertsson 
£ <u 
o c 
zu, "S TS iß © « O *© 
^ g 
s ü 
r® « > 
500 
450 
400 
350 
300 
250 
200 
150 
100 
Syndrome X 
Controls 
Baseline 1,0 2,0 3,0 4,0 5,0 6,0 
Acetylcholine 10 x jjg/kg/min 
Figure V:I Increase in forearm blood flow induced by i.a. infusion of acetylcholine (10-60 
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Figure V:III Flow-mediated dilatation of the brachial artery following release of proximal 
artery occlusion, expressed as a percentage of t he basal (pre-occlusive) vessel diameter. "Control 
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observations and horizontal lines indicate mean values. Levels of significance given in the 
upper part of the figure. 
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Paper VI 
Healthy post-menopausal women did 
not respond with chest pain or ST-
segment depression at exercise, and 
there was no difference in working 
capacity after estradiol treatment 
compared to placebo. 
Of fifteen postmenopausal women 
with syndrome X, twelve had their 
typical chest pain during exercise on 
placebo treatment compared to eight on 
estradiol treatment. 
Time to 1mm ST-segment depression 
increased from 187 ± 43 to 257 ± 38 
seconds (p<0.05), time to angina 
increased from 233 ± 21 to 323 ± 29 
seconds (p<0.01), total exercise time 
increased from 323 ± 22 to 364 ± 27 
seconds (p<0.05), and recovery time 
from angina was reduced from 202 ± 43 
to 150 ± 46 seconds (p<0.05) when 
comparing estradiol treatment with 
placebo. The difference in ST-segment 
depression on maximal workload was 
not significant. However, a higher work­
load was achieved on estradiol treat­
ment (Fig VI:I) and when analysing ST-
segment changes on comparable 
workload, a significant reduced ST-
segment depression was noticed during 
estradiol treatment compared with 
placebo (Fig VI:II). 
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Figure VI:I Workload during placebo and estradiol treatment in patients with 
syndrome X (left bars) and controls (right bars). 
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Figure VI:II ST-segments depression at comparable workload during placebo and 
estrogen treatment in syndrome X patients (left bars) and controls (right bars). 
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Paper VII 
Spinal cord stimulation in patients with 
syndrome X was followed by an 
increased time to 1mm ST-segment 
depression, increased time to angina, 
and an increased maximal workload 
achieved (Table VII:I). 
ST-segment depression on maximal 
workload was not significantly reduced, 
but since a higher workload was 
achieved on spinal cord stimulation, the 
ST-segment depression on comparable 
workload was analysed and was 
demonstrated to be reduced. Time to 
recovery from angina was not 
significantly reduced and the same was 
found for recovery time for ST-segment 
depression. 
The rate pressure product on 
comparable workload was found to be 
increased from 24795 ± 5022 to 28038 + 
6124 mmHG x bpm. This increase in the 
rate pressure product at comparable 
workload during treatment may imply 
an increase in coronary blood flow. 
Table VII:I Results on exercise test during control situation and during spinal cord 
stimulation. 
Control ses P 
Rate pressure product (mmHgxbmp) 24795±5022 28038+6124 <0.01 
Maximal work load (watt) 96±21 108+22 <0.001 
ST-segment depression (mm) 1.5+0.9 1.3±0.8 
ST-segment depression comparable 1.5+0.9 1.0±0.6 <0.01 
TT A (min) 2.66±1.9 5.39+2.16 <0.01 
TT-ST (min) 2.44±1.61 3.50±1.93 <0.01 
ART (min) 4.36±2.98 2.79±4.26 
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DISCUSSION 
Hospitalisation 
Need for hospitalisation describes the 
morbidity since it could be an 
expression of severe symptoms. The 
present study (Paper I) was nevertheless 
not designed to investigate if th ere really 
was an improvement in symptoms 
during two years of follow up which 
had previously been reported (Bemiller 
et al 1973, Isner et al 1981). Except for 
improvement of symptoms, a reduction 
of h ospitalisation could be a reassurance 
for both patients and physicians that no 
serious coronary artery disease is 
present (Ockene et al 1980), and 
consequently observation after an attack 
of chest pain is regarded as unnecessary. 
The decrease of hospitalisation in 
Paper I is totally owing to reduction of 
hospitalisation due to cardiac reasons. 
The increase in use of medical resources 
due to non-cardiac reasons after the 
diagnostic angiogram can be explained 
by the fact that a diagnosis other than 
angina pectoris was given when patients 
were hospitalised due to chest pain (e.g. 
oesophagus or musculoskeletal 
disorders). It is however important to 
stress that it is possible that "other 
diseases" were less common during two 
years prior the diagnostic angiogram 
compared to two years after, since the 
patients were older during the latter 
period, and it is reasonable to suggest 
that utilisation of medical resources 
increases with age. With this in mind the 
result of a reduction in total need for 
hospitalisation is even more beneficial. 
Quality of life 
Self-estimation of quality of life 
represents the patients view of the 
disease's impact on his social life. 
All instruments, NHP I, NHP II, PGWB 
and PAS, used in the present study 
(Paper II) are well documented and 
validated (Hunt et al 1980, 1981, Dupuy 
1984, Wiklund et al 1988). The advantage 
of u sing a specific questionnaire (PAS) is 
its ability to detect effects of an 
intervention in selected patient 
populations (Wiklund et al 1990) NHP 
and PGWB constitute general 
questionnaires. They are often used in 
epidemiological studies, and since 
reference scores are available (stratified 
for sex and age) it is possible to compare 
data from different population studies. 
NHP is most useful among patients with 
chronic diseases and severe symptoms. 
PGWB is a more generalised instrument 
which can be used to detect the impact 
of any symptoms on the quality of life 
and could even be used in a healthy 
populations. 
Our data showed unexpectedly that 
patients with normal or near normal 
coronary angiograms demonstrated 
inferior quality of life compared with 
patients with coronary stenoses. They 
also seem to have at least as severe pain 
as patients with coronary stenoses. Since 
it is well known that young patients and 
females perceive their health as poorer 
all data were adjusted for sex and age 
(since patients with normal or near 
normal coronary angiograms were 
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younger and included more females), 
but the differences remained significant 
in most parameters. Earlier studies have 
indicated that there is a high psychiatric 
morbidity among patients with chest 
pain without significant stenoses (Bass et 
al 1984). A self-administered question­
naire designed to address quality of life 
is probably not a sensitive enough tool 
to detect psychiatric morbidity, but it is 
interesting to notice that we found small 
but significant differences in the 
subscale anxiety between the groups. 
Finally, it is important to emphasise 
that the questionnaires were adminis­
tered to the patients prior to the 
angiogram and the responses should not 
be biased by the angiographic result, 
and not by the physicians attitude 
towards a patient without significant 
stenosis 
Miid stenoses versus completely 
normal angiogram 
As previously mentioned, earlier 
reports have been successful in 
demonstrating a more beneficial 
prognosis in patients with chest pain 
and normal angiograms compared to 
patients with mild stenoses. It has 
furthermore been suggested that there 
are different mechanisms behind the 
chest pain in the two groups. However, 
in Paper I the background data and 
outcome in terms of hospitalisation was 
very similar in the two groups, with 
more hospitalisations due to myocardial 
infarction among patients with mild 
stenoses as the only significant 
difference. Paper II also demonstrated 
very homogenous results between the 
two groups regarding quality of life. 
Exercise test 
ST-segment changes is a rather blunt 
method for identification of ischemia, 
especially in females. In the CASS 
registry (matched for age and pre­
valence and severity of coronary artery 
disease, CAD), the specificity for 
predicting CAD was 64% in women 
compared to 73% in men (Weiner et al. 
1979). Simultaneously there were no 
difference in sensitivity; 78 vs 76%. 
Regarding patients with normal 
coronary angio-grams, the specificity 
and sensitivity to predict a reduced 
coronary vasodilator reserve with 
exercise test (analysing ST-segment 
depression) was 45 and 86% respectively 
(Camici et al. 1992). 
Still, it is the most common examina­
tion that distinguishes between ischemia 
and non ischemia. Almost every patient 
referred for coronary angiogram has 
performed the test and we therefore also 
used it in the definition of syndrome X. 
In Paper I there were no differences 
between patients with normal or near 
normal angiograms whether the exercise 
tests were positive or not, and the same 
was found in Paper II. This is in 
contradiction to Paper III a nd IV where 
the exercise tests were able to show a 
distinction between patients with 
positive or negative exercise tests. 
It is very important to emphasise that 
in the two latter papers both the patient 
group (syndrome X) and the control 
group were carefully selected. Patients 
were recruited not only with a positive 
exercise test but also with typical 
exertion angina pectoris showing a good 
response to sublingual nitro and also if 
an ischemic heart condition was 
clinically suspected to be the origin 
behind chest pain. The control groups in 
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these papers were, on the other hand, 
subjects with negative exercise tests and 
atypical chest pain and its origin was not 
believed to be an ischemic heart 
condition. The two groups in these 
papers subsequently constituted two 
extremes of a continuous spectrum 
among patients with normal or near 
normal coronary angiogram where both 
false positive and false negative exercise 
tests are probably quite common. 
There are however suggestions that 
patients with positive and negative 
exercise tests constitute two different 
aspects of microvascular angina. ïn a 
study by Frabert and co-workers 
regarding heart rate variability in 
patients with chest pain and micro­
vascular angina it was found that only 
patients with a normal exercise tests 
showed an abnormal heart rate 
variability indicating a defect in the 
sympathetic balance as a possible 
pathogenic factor in this subgroup of 
patients (Frabert et al 1995), whereas 
patients with a positive exercise test 
exhibited no signs of autonomic 
dysfunction. 
Rapid atria] pacing 
Atrial pacing has long since been used 
for induction of "experimental angina" 
(Sowton et al. 1967). The increase in 
myocardial demand during increment of 
heart rate produces vasodilatation of the 
microcirculation by autoregulatory 
control (Berne et al. 1979). The increase 
of shear activates mechanoreceptors on 
the endothelium, stimulating pro­
duction and release of nitric oxide (NO) 
leading to appropriate vasodilatation to 
meet the demand (Pohl et al 1986). Thus, 
the flow increase during rapid atrial 
pacing is partially dependent on 
endothelial function. 
One should keep in mind that there 
are drawbacks with atrial pacing as a 
method for induction of myocardial 
ischemia. First; ischemia is not induced 
solely by an increase of heart rate in 
most patients. Second; the method is not 
physiological in increasing heart rate 
since atrial pacing is accompanied by an 
increased PQ-time, whereas in exercise 
induced tachycardia the PQ-time is 
decreased. 
Furthermore there are aspects other 
than vascular factors that influence the 
flow and vascular reserve during 
pacing. The contractility is probably not 
identical during pacing and 
physiological tachycardia, and if for 
example, an increased left ventricular 
end diastolic pressure is present, this can 
increase the extravascular component of 
the flow resistance. The reduction in 
flow increase in patients with syndrome 
X after atrial pacing in Paper III is 
nevertheless interesting but one should 
keep in mind that this is mainly due to 
an increased basal flow in these patients 
compared to the controls, and the 
absolute maximal flow was similar in 
the two groups - a speculation is that the 
reduction in flow response in syndrome 
X patients is due to a defect vaso­
dilatation capacity for example based on 
endothelial dysfunction. 
Adenosine provocation 
In our opinion Adenosine may be the 
ideal substance for inducing maximal 
coronary flow. It could be given as a 
bolus and have a very short half-life (5-
10 sec). Adenosine reacts with at least 
four different receptors (Al, A2a, A2b 
and A3), and is not dependent on a 
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normal endothelial function for 
vasodilatation (Fredholm et al 1994). In 
previous reports dipyridamole has been 
the most widely used drug for induction 
of maximal vasodilatation. It acts by 
inhibiting cellular uptake of adenosine, 
resulting in an increased concentration 
of adenosine which induces vaso­
dilatation. When adenosine has been 
compared to dipyridamole, the former 
has been the most efficient (Holdright et 
al. 1993, Finnochiaro et al. 1994). The 
vasodilator response after dipyridamole 
has been shown to be variable (Rossen et 
al. 1989), whereas recruitment of 
coronary reserve by adenosine infusion 
appears to be consistent and near 
maximal (Wilson et al. 1990). The effect 
of left ventricular dysfunction in Paper 
IV is more difficult to explain. Obviously 
there is a difference between a bolus 
dose of adenosine and continuous 
administration (Lagerqvist et al. 1992). A 
bolus dose induces maximal dilatation 
and the chest pain is often not related to 
ischemia, whereas a steady-state 
infusion has the ability to induce 
ischemia, most probably by a coronary 
steal mechanism (Edlund et al. 1991). 
Adenosine vs. atrial pacing 
In Paper III we demonstrated that 
patients with syndrome X have a 
reduced coronary vasodilator capacity 
after rapid atrial pacing whereas it is 
normal after adenosine provocation. The 
difference in mechanism of action 
between the two methods can account 
for the discrepancy. Since the epicardial 
arteries had neither fixed stenosis, nor 
inducible spasm and offered little 
resistance to flow, the abnormality 
appears to originate from the micro­
circulation. The finding of reduced flow 
reserve on pacing but not after 
adenosine, indicates that patients with 
syndrome X have a selective impairment 
of flow increase to some stimuli whereas 
flow increase is normal to others. This 
study was not designed to investigate 
endothelium function (in which case 
acetylcholine administration would have 
been preferable), but a speculation is 
that patients with syndrome X ha ve an 
impaired production, impaired release 
or excessive degradation of endothelium 
derived relaxing factor. 
Coronary sinus flow measurements 
We employed the sinus coronary 
thermodilution technique for flow 
measurement, since it was the only 
method available when the study was 
initiated. This method has some clear 
limitations. Phasic coronary flow or 
rapid changes in flow cannot be assessed 
correctly when this technique is applied. 
Furthermore, perfusion to the right 
ventricle cannot be assessed due to the 
anatomy of the venous drainage, and 
flow in specific transmural layers cannot 
be estimated (Marcus et al. 1987). The 
position of the catheter is very crucial 
and it should be checked repeatedly 
during the procedure. If the catheter is 
too close to the ostium of the coronary 
sinus, there are possibilities that efflux 
from the atrium could affect the 
measurements. Furthermore, blood can 
be "diluted" by tributary draining areas 
of the heart, other than the left ventricle. 
Bagger showed that blood flow can 
change from 23 to 68 ml/min per 
centimetre catheter movement, and in 
addition forced inspiration can increase 
the sinus flow two-fold (Bagger 1984). 
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Concept of coronary flow reserve 
Coronary reserve is expressed as the 
ratio between maximal flow which could 
be induced, and basal flow. Using the 
ratio rather than absolute flow makes it 
more efficient to compare different 
methods of measurement and different 
groups of patients. With this technique, 
however, it is impossible to determine if 
a reduction in flow reserve is due to 
reduced maximal flow or increased 
basal flow. Furthermore statement of 
flow reserve necessitates that the flow 
induced really is maximal (L'Àbbate et 
al. 1992). If we consider the flow 
obtained as maximal, however, it still 
does not take into account a second 
dimension of coronary reserve, the 
perfusion pressure (Klocke 1987). Flow 
measurements and then flow reserve 
calculations may be different depending 
on the corresponding coronary pressure. 
It should be emphasised that at each 
pressure level, the auto-regulatory curve 
moved up and down depending on 
beat-to-beat changes in myocardial 
metabolic demand, and the slope of the 
relation between coronary flow and 
coronary pressure is also affected by the 
heart rate (reduction in diastolic 
perfusion time). 
The abundance of evidence of a 
reduced flow reserve is listed in Table 1, 
page 15, but a crucial question is if flo w 
reserve impediment is always 
equivalent with myocardial ischemia. 
Theoretically this does not need to be 
the case if t here is a decrease in cardiac 
performance to match a lower energy 
supply, such as in hibernating 
myocardium (Fedele et al. 1988). There is 
no evidence however that a reduced 
basal flow or a reduction in cardiac 
work and performance is present in 
syndrome X. 
An almost opposite situation could 
also explain a condition with reduced 
vascular reserve in absence of ischemia. 
In the presence of an increased cellular 
"efficiency" with a large extraction of O 2 
and substrates, this could be achieved 
but there are no experimental data 
supporting this theory. Investigations 
have, on the other hand, shown that 
patients with syndrome X have a normal 
pO2 level during pacing (Crake et al. 
1988), and a low intracellular energy 
charge (Waldenström et al. 1992). The 
most important opposing factor comes 
from the fact that in most works, 
including Paper III in this thesis, the 
reduced vascular reserve is accom­
panied by metabolic changes such as 
low lactate extraction or lactate 
production indicative of ischemia. 
Myocardial metabolism 
The normal oxygenated and perfused 
myocardium extracts lactate. A low 
extraction rate (<10%) indicates 
ischemia. Severe ischemia leads to 
anaerobic glycolysis in the tissue 
resulting in a release of lactate into the 
venous effluent (e.g coronary sinus), 
while at the same time the systemic 
arterial lactate concentration remains 
stable, a higher content will be found in 
the vein - lactate production - which is 
the only certain indication of ischemia. 
Absence of lactate production does not 
rule out ischemia, since lactate produced 
by ischemic tissues may be diluted in the 
coronary sinus effluent by drainage 
from non-ischemic areas (Gertz et al. 
1980), or ischemia may be present in an 
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area not drained to the distal part of the 
coronary sinus or great cardiac vein 
were blood was collected (Hood 1968). 
Nevertheless myocardial lactate pro­
duction has been demonstrated in 
syndrome X. 
This is in accordance with the findings 
in Paper III, where we could demons­
trate lactate production in 4 of 13 
patients with syndrome X. 
Forearm endothelial function 
Endothelial dysfunction has been 
demonstrated to be involved in several 
form of vascular disease, for example in 
hypercholesterolemia it has been shown 
to be a universal vascular phenomenon 
(Creager et al 1990). Egashira and co­
workers have very convincingly 
demonstrated that patients with 
syndrome X have an endothelial dys­
function, contributing to the reduced 
vasodilator capacity (Egashira et al 
1993). This study was however designed 
to investigate the coronary circulation 
only and did not address the question of 
a generalised disorder in the endothelial 
lining. The classical work by Sax and 
Cannon (Sax et al 1987) has earlier been 
shown to demonstrate that patients with 
microvascular angina have a blunted 
flow response and increased vascular 
resistance in the forearm after arterial 
occlusion. This reactive hyperaemia in 
the resistance vessel is however not 
mainly dependent on a normal 
endothelial function and the mechanism 
underlying this abnormal flow response 
was not obvious. 
In our studies we could not demons­
trate an abnormal endothelial dependent 
flow response in the resistance vessels 
after acetylcholine provocation, a 
method that has been extensively used 
and is very well validated. The use of 
acetylcholine provocation originates 
from the pioneer works of Furchgott and 
with this method an endothelial 
dysfunction has been revealed in 
patients with coronary heart disease, 
hypertension and hypercholesterolemia 
(Ludmer et al 1986, Panza et al 1990, 
Creager et al 1990). Flow-mediated 
diameter increase in the conduit vessel 
(brachial artery) that can be detected by 
ultrasound, has been extensively used 
during last years and is today an 
established method. For example, 
patients at risk for atherosclerosis and 
passive smokers have been 
demonstrated to display a reduced 
endothelial function (Celermajer et al 
1992,1996) 
Our findings in Paper V very strongly 
disfavour the theory of a generalised 
endothelial disorder in syndrome X. It is 
important to address the fact that only 
three of altogether 21 patients with 
syndrome X w ho we investigated were 
smokers and none had hypertension or 
hypercholesterolemia - factors that could 
all have influenced the result. 
Effect of estradiol 
The classical action of steroid hormone 
is the gene activation pathway. Estrogen 
receptors have been demonstrated in 
different cell types and recently even in 
vascular tissue (Venkov et al 1995), but 
there is no evidence of their presence in 
coronary arteries (Collins et al 1996). 
There are other modes of action for 
estrogen's effect on vascular reactivity, 
including endothelium dependent flow 
increase and blockade of the cell 
membrane voltage-dependent calcium 
channels (Jiang et al 1992). 
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Our findings of a beneficial effect for 
exercise capacity in Paper VI can 
probably be explained by a reduction of 
ischemia due to a vasodilatation induced 
by estrogen. Since there were no 
significant difference compared to 
placebo in heart rate and blood pressure 
(rate pressure product) on peak exercise, 
peripheral mechanisms cannot explain 
the benefit and we speculate that a direct 
coronary vasodilator effect is more 
likely. Estrogen also showed to improve 
endothelium dependent forearm flow in 
Paper V, but there were no significant 
difference compared to placebo in this 
study, which does not support the fact 
that estrogen deficiency is a general 
feature in syndrome X. The discrepancy 
between the findings in Papers V and VI 
(performed mainly on the same subjects) 
indicates that the beneficial effect seen 
on exercise capacity and ischemia is not 
mediated via an endothelium dependent 
mode of action, unless the disease is 
localized to the coronary arteries only. 
Another explanation is that estrogen 
generally acts different on different 
vascular beds, and this field is open for 
debate and future research. It is also 
important to address the fact that the 
beneficial effect of estrogen has been 
demonstrated in short term studies only. 
There are suggestions that estrogens 
beneficial effect on endothelium-
dependent flow will be reduced during 
long-term treatment. There are also 
concerns about the use of a combination 
of p rogesterone and estrogen since there 
are data supporting that progesterone 
substantially reduces the beneficial 
effects of estrogen. 
Effect of spinal cord stimulation. 
To our knowledge Paper VII is the first 
report of a beneficial effect with spinal 
cord stimulation in syndrome X. Several 
studies have demonstrated that the anti­
anginal effect of spinal cord stimulation 
(SCS) is related to an anti-ischemic effect 
(Mannheimer et al 1988, Sanderson et al 
1992). It has been demonstrated that 
during experimentally induced angina 
SCS can reverse lactate production into 
lactate extraction and reduce myocardial 
oxygen consumption in patients with 
coronary artery stenoses (Mannheimer et 
al 1993). 
In the present study an increase in 
rate pressure product (RPP) was 
observed during treatment with SCS. 
This may imply an increase in coronary 
blood flow since RPP has been 
demonstrated to correlate well with 
myocardial oxygen consumption (Bailer 
et al 1980, 1981). Studies are ongoing to 
clarify if the mechanism of action of SCS 
differs between patients with syndrome 
X and patients with coronary artery 
stenoses. 
A limitation with the present study is 
that it is impossible to do a blind 
control/treatment study either for the 
investigator or the patient. This may 
produce an placebo effect, and for 
example the increase in working 
capacity that was found is in the same 
magnitude that has been reported for 
placebo. Our clinical experience with 
SCS in patients with syndrome X is 
though very positive and all patients 
voiced satisfied with this treatment. 
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GENERAL CONCLUSIONS 
1. Of 29362 patients performing coronary angiography due to chest pain, 63 
(6%) were found to lack significant stenoses. Of these 113 demonstrated 
completely normal angiograms and 50 had mild (<50%) stenoses. Half of the 
patients without significant stenoses showed a positive exercise test. 
2. Patients with normal or near normal coronary angiograms were younger 
and included more women (50% vs. 20%) than patients with coronary artery 
stenoses. They suffered less often from diabetes and had less often a previous 
cerebrovascular disease or myocardial infarction. During two years prior to 
the angiogram 66% of the patients with normal or near normal coronary 
artery stenoses had been hospitalised, compared to 35% during two years 
after the diagnostic procedure. This reduction in need for use of medical 
resources indicates that a negative coronary angiogram is of great value for 
the patient and thé physician. 
3. Patients with normal or near normal coronary angiograms show an inferior 
quality of l ife (measured with self-administered questionnaires) compared to 
patients with coronary artery stenoses. This included in Nottingham Health 
Profile subscales concerning pain, energy, mobility, sleep and emotions, and 
in Psychological General Well-Being Index subscales related to vitality, anxiety 
and well-being. This is an important observation for the future care of these 
patients. 
4. Selected patients with syndrome X s howed a normal maximal coronary 
flow reserve compared with controls when provoked with adenosine 
intracoronary. The flow increase after atrial pacing (which is partially 
endothelium-dependent) was lower among patients with syndrome X (1.5 vs. 
2.2). Spasm was not induced in any subject by provocation with ergonovine. 
5. Myocardial lactate extraction during rapid atrial pacing was insignificantly 
lower among patients with syndrome X compared with controls, but lactate 
production (the only definite proof for ischemia) was achieved in four 
patients with syndrome X and in none of the controls. 
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6. Adenosine infusion with simultaneous echocardiographic examination 
seems to be a valuable diagnostic tool in patients with chest pain and normal 
coronary angiogram. Among 20 patients with syndrome X, 14 subjects 
showed signs of regional left ventricular dysfunction during provocation, 
compared to only 4 of 17 subjects with atypical chest pain and a negative 
exercise test. The reaction with left ventricular dysfunction could imply that 
ischemia is induced by adenosine infusion in this group of pa tients. 
7. Endothelium-dependent (acetylcholine infusion) and endothelium-
independent (nitroprusside infusion) forearm resistance vessel response did 
not differ between patients with syndrome X and healthy controls. 
Endothelium dependent conduit vessel responses was also unaffected in 
patients with syndrome X. 
Endothelial dysfunction does not seem to be a universal phenomenon in 
syndrome X. 
8. Transdermal estradiol improved the endothelium-dependent flow in the 
brachial artery to the same extent in patients with syndrome X and in 
controls. On the other hand transdermal estrogen showed a beneficial 
response to syndrome X patients on exercise capacity, angina pectoris and ST-
segment changes during bicycle exercise tests compared with placebo. 
Estrogen does seem to have a beneficial effect on myocardial ischemia in 
postmenopausal women with syndrome X and may in the future be a useful 
therapeutic agent in selected patients. 
9. Spinal Cord Stimulation seem to be of benefit to patients with syndrome X. 
Exercise tolerance improved (from 96 to 108 watts) and the magnitude of ST-
segment depression decreased on comparable workload. Furthermore time to 
angina and time to appearance of significant ST-segment depression 
increased. These effects are probably associated with a reduction of 
myocardial ischemia. 
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